seborrheic dermatitis: A dermatitis that is an inflammatory skin condition resulting in flaky, white to yellowish scales on oily areas such as the scalp or inside the ear, which is caused due to a combination of an over production of skin oil and irritation from a yeast Malassezia furfur. The symptoms include itching, skin lesions and scales, redness, plaques and hair loss.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3907 |
4. Check minimum number of eventsNone |
3907 |
5. Include endpointsNone |
3907 |
6. Filter based on genotype QC (FinnGen only) |
3907 |
Control definitions (FinnGen only)
- Control exclude
- L12_DERMATITISECZEMA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L20-L30
- Name in latin
- Eczema seborrhoicum
Similar endpoints
↥List of similar endpoints to
Seborrhoeic dermatitis
based on the number of shared cases.
Similar with more cases:
- Dermatitis and eczema
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 27055 | 10631 | 16244 |
| Only index persons | 24323 | 9856 | 14467 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.39 | 0.30 | 0.45 |
| Only index persons | 0.48 | 0.36 | 0.55 |
| Median age at first event (years) | |||
| Whole population | 51.96 | 48.40 | 54.18 |
| Only index persons | 51.03 | 48.14 | 52.99 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3907 | 1670 | 2237 |
| Unadjusted period prevalence (%) | 0.81 | 0.57 | 0.99 |
| Median age at first event (years) | 54.99 | 49.36 | 59.20 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3492
- Matched controls
- 34921
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D07XC01
ATC
betamethasone, combinations; topical
7.6
323.0
1088
1953
E0000UV
ATC
NA
4.1
323.0
1867
7612
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
164.9
323.0
1204
111
D07AB02
ATC
hydrocortisone butyrate; topical
5.5
323.0
1675
5036
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
305.4
323.0
1255
64
L30.9
ICD-10 Finland
Dermatitis, unspecified
8.6
323.0
1088
1751
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
4.9
323.0
1423
4334
D07AC01
ATC
betamethasone; topical
4.5
323.0
1770
6476
L21.0
ICD-10 Finland
Seborrhoea capitis
261.3
323.0
924
48
L20.0
ICD-10 Finland
Besnier prurigo
+∞
314.4
297
*
L21
ICD-10 Finland
Seborrhoeic dermatitis
29.8
284.6
389
146
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
7.3
272.1
718
1191
XQ802
NOMESCO Finland
Epicutan test
35.7
251.3
328
101
E000001
ATC
NA
4.2
226.2
1057
3305
D07AC13
ATC
mometasone; topical
3.6
223.0
1355
5286
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
+∞
209.5
199
*
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
6.6
193.8
541
940
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
4.6
179.0
702
1804
D07AA02
ATC
hydrocortisone; topical
4.3
168.1
715
1979
D07BA04
ATC
hydrocortisone and antiseptics; topical
4.7
143.3
534
1280
D07AB08
ATC
desonide; topical
4.6
133.2
505
1226
D07AD01
ATC
clobetasol; topical
3.5
128.5
694
2308
TQW80
NOMESCO Finland
Local dermatologic skincare
14.3
128.1
224
167
XQ800
NOMESCO Finland
Prick test
5.9
123.9
371
688
L57.0
ICD-10 Finland
Actinic keratosis
4.2
123.6
529
1439
L30.3
ICD-10 Finland
Infective dermatitis
18.4
115.4
182
104
D06BX01
ATC
metronidazole; topical
3.6
103.3
530
1668
69009
ICD-8 Finland
Seborrhoeic dermatitis, Unspecified
+∞
98.4
94
*
H02AB06
ATC
prednisolone; systemic
2.0
86.5
1659
10693
XQ848
NOMESCO Finland
Dermatological photography
8.5
85.2
194
241
L71.9
ICD-10 Finland
Rosacea, unspecified
8.9
84.8
187
220
E000002
ATC
NA
3.3
79.4
447
1491
J01AA07
ATC
tetracycline; systemic
2.7
79.1
639
2703
L40.0
ICD-10 Finland
Psoriasis vulgaris
5.0
74.0
253
539
J01DB01
ATC
cefalexin; oral
2.1
73.5
2829
23226
J01AA04
ATC
lymecycline; systemic
2.7
73.2
567
2331
E0001A1
ATC
NA
8.8
72.8
161
190
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
7.0
72.1
186
279
6900A
ICD-9 Finland
Erythematosquamous dermatosis[ECZEMA SEBORRHOICUM]
+∞
69.0
66
*
L20
ICD-10 Finland
Atopic dermatitis
+∞
67.9
65
*
L71.8
ICD-10 Finland
Other rosacea
12.5
66.5
122
101
E000006
ATC
NA
3.8
64.6
295
829
L73.8
ICD-10 Finland
Other specified follicular disorders
17.3
63.2
101
60
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
165.5
62.1
65
*
L30.0
ICD-10 Finland
Nummular dermatitis
7.1
62.0
157
229
R06AE07
ATC
cetirizine; oral
1.9
62.0
1416
9351
D10BA01
ATC
isotretinoin; oral
3.7
60.9
290
843
J02AC01
ATC
fluconazole; systemic
1.9
56.2
1215
7799
J02AC02
ATC
itraconazole; systemic
2.2
54.6
655
3330
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
+∞
54.3
52
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.8
54.0
1282
8463
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
186.2
53.1
55
*
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.4
52.5
496
2245
D07CC01
ATC
betamethasone and antibiotics; topical
2.5
52.2
459
1998
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
52.0
997
6095
D07BC01
ATC
betamethasone and antiseptics; topical
2.5
51.5
434
1847
D02AE01
ATC
carbamide; topical
3.4
51.2
261
799
D05AX52
ATC
calcipotriol, combinations; topical
3.4
50.6
261
807
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
50.5
988
6072
S29
ICPC
Skin symptom/complaint other
2.2
50.2
598
3019
L30.8
ICD-10 Finland
Other specified dermatitis
9.0
48.2
104
118
ZXC50
NOMESCO Finland
Cryotherapy
5.0
47.7
160
333
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
47.5
1153
7582
L04AX01
ATC
azathioprine; systemic
3.8
47.2
212
585
L82
ICD-10 Finland
Seborrhoeic keratosis
2.2
46.1
546
2741
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
5.2
45.2
145
287
L20.8
ICD-10 Finland
Other atopic dermatitis
+∞
44.9
43
*
J01DA01
ATC
[U] cefalexin; systemic
1.7
44.6
2056
16182
S18
ICPC
Laceration/cut
1.7
44.4
1402
9927
E000007
ATC
NA
3.6
42.1
199
573
L29.9
ICD-10 Finland
Pruritus, unspecified
7.4
41.9
102
141
M25.5
ICD-10 Finland
Pain in joint
1.8
41.6
900
5657
XQ845
NOMESCO Finland
Dermatoscopy
8.5
41.0
91
109
E000003
ATC
NA
4.0
40.9
169
433
D02AX
ATC
Other emollients and protectives
5.3
40.4
128
250
N03AX16
ATC
pregabalin; oral
1.8
40.1
772
4657
127
Kela drug reimbursment
Transplant complication
6.8
39.8
103
156
SPAT1153
SPAT
Removal of sutures
1.7
39.7
1061
7098
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
39.5
1412
10241
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.8
39.4
175
478
L04AD01
ATC
ciclosporin; systemic
6.0
39.4
112
192
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
39.4
715
4221
N02BE01
ATC
paracetamol; systemic, rectal
1.8
39.1
2829
24724
R06AE09
ATC
levocetirizine; oral
2.2
39.0
462
2304
A02BC02
ATC
pantoprazole; systemic
1.6
38.9
2083
16749
L04AA06
ATC
mycophenolic acid; systemic
6.6
38.3
101
157
D11AH01
ATC
tacrolimus; topical
381.4
38.1
38
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.0
38.0
127
264
R06AX27
ATC
desloratadine; oral
1.8
37.9
810
5045
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.1
37.7
484
2498
N03AX12
ATC
gabapentin; oral
2.0
37.5
510
2696
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.0
37.1
527
2834
UJF32
NOMESCO Finland
Coloscopy
1.7
36.0
835
5322
C03CA01
ATC
furosemide; systemic
1.7
35.7
878
5695
SPAT1301
SPAT
No procedures
1.7
35.5
1048
7163
L70.0
ICD-10 Finland
Acne vulgaris
5.1
35.5
115
231
TQW99
NOMESCO Finland
Other minor procedure on skin
3.1
35.2
204
685
H04.10
ICD-10 Finland
Dry eye syndrome
2.4
35.1
326
1448
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.3
34.2
332
1505
L28.0
ICD-10 Finland
Lichen simplex chronicus
26.4
34.1
47
18
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
33.8
1294
9440
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
33.6
569
3260
M54.5
ICD-10 Finland
Low back pain
1.6
33.3
1010
6928
J01FF01
ATC
clindamycin; systemic
1.7
33.2
875
5767
H02AB04
ATC
methylprednisolone; systemic
2.0
33.0
477
2574
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
91.0
32.8
36
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
32.4
459
2457
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
10.3
32.3
64
63
M79.6
ICD-10 Finland
Pain in limb
1.6
32.1
1075
7552
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.7
32.0
895
5991
SPAT1310
SPAT
Counselling related to known health issue
1.6
32.0
1018
7057
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.6
31.9
249
1006
L30.4
ICD-10 Finland
Erythema intertrigo
9.2
30.8
65
72
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
2.6
30.7
236
946
L23.5
ICD-10 Finland
Allergic contact dermatitis due to other chemical products
111.0
30.7
33
*
R03AC02
ATC
salbutamol; inhalant
1.5
30.7
1600
12468
N06AX11
ATC
mirtazapine; oral
1.6
30.7
967
6674
A02BC01
ATC
omeprazole; systemic
1.7
30.4
858
5743
SPAT1263
SPAT
Sampling
1.5
30.4
1353
10163
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
30.2
415
2192
N02AX02
ATC
tramadol; systemic, rectal
1.5
29.8
1356
10221
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.0
29.7
433
2340
N06AX21
ATC
duloxetine; oral
2.2
29.7
342
1677
N06AB04
ATC
citalopram; systemic
1.7
29.6
659
4112
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.1
29.5
361
1816
Z94.0
ICD-10 Finland
Kidney transplant status
7.1
29.4
73
105
A46
ICD-10 Finland
Erysipelas
1.9
29.3
460
2554
N05AH04
ATC
quetiapine; oral
1.8
29.3
527
3071
ZXC15
NOMESCO Finland
Use of photodynamic technique
6.5
28.8
76
119
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
23.0
28.7
41
18
WX110
NOMESCO Finland
Local anesthesy
1.5
28.6
2184
18381
Z00.0
ICD-10 Finland
General medical examination
1.8
28.5
599
3666
L28
ICPC
Limited function/disability (L)
1.9
28.2
480
2742
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
3.6
28.1
132
379
A02BC03
ATC
lansoprazole; oral
1.6
28.1
897
6184
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
28.0
1279
9607
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
27.8
1226
9133
S01GX01
ATC
cromoglicic acid; ophthalmic
1.8
27.5
553
3337
L04AA01
ATC
[U] ciclosporin; systemic
5.6
27.4
81
147
J01AA02
ATC
doxycycline; systemic
1.5
27.4
2460
21335
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
27.3
1194
8869
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.2
27.3
294
1400
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
+∞
27.1
26
*
B35.3
ICD-10 Finland
Tinea pedis
3.1
27.1
151
494
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.6
27.1
1012
7245
G47.3
ICD-10 Finland
Sleep apnoea
1.7
27.0
715
4681
D05AX02
ATC
calcipotriol; topical
3.0
27.0
162
558
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
2.1
27.0
319
1582
L85.3
ICD-10 Finland
Xerosis cutis
8.8
26.9
58
67
N06AA09
ATC
amitriptyline; systemic
2.1
26.6
318
1583
D10AX03
ATC
azelaic acid; topical
2.5
26.6
224
945
R06AX22
ATC
ebastine; oral
1.8
26.5
493
2894
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.7
26.4
193
751
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
9.0
26.4
56
63
J02AB02
ATC
ketoconazole; oral
3.6
26.1
122
349
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.1
26.1
300
1468
N05BA01
ATC
diazepam; systemic, rectal
1.9
25.7
425
2400
A02BC05
ATC
esomeprazole; systemic
1.5
25.6
1217
9176
B07.9
ICD-10 Finland
Verruca simplex
3.2
25.3
138
445
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
25.3
717
4774
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
25.2
463
2704
L03
ICPC
Low back symptom/complaint
1.6
25.2
689
4542
S21
ICPC
Skin texture symptom/complaint
1.9
25.1
387
2128
R01AD09
ATC
mometasone; nasal
1.5
25.1
1326
10213
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.4
25.0
224
972
L71.0
ICD-10 Finland
Perioral dermatitis
6.4
24.8
66
105
N05BB01
ATC
hydroxyzine; systemic
2.6
24.8
191
767
SPAT1312
SPAT
General health counselling
1.5
24.6
991
7186
R06.0
ICD-10 Finland
Dyspnoea
1.6
24.3
737
4982
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.4
24.3
212
910
D07XB02
ATC
triamcinolone, combinations; topical
5.3
24.3
75
144
N05BA04
ATC
oxazepam; oral
1.6
24.3
724
4873
R42
ICD-10 Finland
Dizziness and giddiness
1.7
24.2
632
4106
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.4
23.9
215
938
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
23.5
947
6849
SPAT1216
SPAT
Assessment of functional ability
1.8
23.5
465
2780
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
23.5
846
5963
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
23.4
383
2149
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
23.3
277
1375
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.6
23.3
819
5740
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
23.2
597
3859
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
23.1
723
4918
L21.1
ICD-10 Finland
Seborrhoeic infantile dermatitis
+∞
22.9
22
*
R50.9
ICD-10 Finland
Fever, unspecified
1.8
22.9
447
2662
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
22.9
1961
16503
J01MA02
ATC
ciprofloxacin; systemic
1.5
22.9
1201
9185
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
22.9
2167
18587
N05CF01
ATC
zopiclone; oral
1.5
22.8
940
6826
L17
ICPC
Foot/toe symptom/complaint
1.6
22.6
732
5022
Z01.2
ICD-10 Finland
Dental examination
1.5
22.5
1231
9485
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
20.8
22.5
33
16
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.4
22.5
112
338
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.9
22.4
351
1940
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
22.3
505
3144
A02BA02
ATC
ranitidine; systemic
1.6
22.3
590
3836
SPAT1260
SPAT
Consultation of another employee
1.7
22.3
540
3428
H13
ICPC
Plugged feeling ear
1.7
22.2
568
3663
N06AX16
ATC
venlafaxine; oral
1.8
22.0
407
2380
R53
ICD-10 Finland
Malaise and fatigue
1.6
21.9
589
3850
N03AE01
ATC
clonazepam; systemic
2.4
21.9
201
883
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
5.0
21.9
71
145
D07AC14
ATC
methylprednisolone aceponate; topical
2.9
21.8
140
503
137
Kela drug reimbursment
Uraemia requiring dialysis
7.8
21.7
50
65
L50.3
ICD-10 Finland
Dermatographic urticaria
5.7
21.4
62
111
J01FA06
ATC
roxithromycin; oral
1.4
21.4
1187
9151
P01AB01
ATC
metronidazole; oral, rectal
1.5
21.4
1119
8524
H03AA01
ATC
levothyroxine sodium; systemic
1.6
21.3
616
4099
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
21.1
1277
10003
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
21.1
1391
11077
D01AC02
ATC
miconazole; topical
2.1
21.1
261
1318
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
21.0
334
1853
R13
ICD-10 Finland
Dysphagia
2.3
20.9
204
926
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
20.9
513
3263
D05BB02
ATC
acitretin; oral
3.8
20.9
89
237
S06
ICPC
Rash localized
2.4
20.9
179
763
G44.2
ICD-10 Finland
Tension-type headache
1.8
20.9
372
2145
J01CA04
ATC
amoxicillin; systemic
1.5
20.8
2564
22885
ZY010
NOMESCO Finland
Hospital outpatient
2.6
20.8
158
629
UKC02
NOMESCO Finland
Cystoscopy
1.7
20.8
521
3337
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
6.8
20.7
52
77
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
20.7
409
2440
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.1
20.6
118
395
AA1AD
NOMESCO Finland
CT of head and brain
1.6
20.5
705
4888
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
20.4
800
5720
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
20.3
1557
12721
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
4.7
20.1
69
150
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.5
20.1
96
282
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
20.0
492
3128
SPAT1229
SPAT
Assessment of need for aid
2.1
20.0
249
1259
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.1
20.0
238
1181
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.2
20.0
76
183
A12AA04
ATC
calcium carbonate; oral
4.4
19.9
73
170
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.1
19.8
240
1198
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
19.8
1726
14402
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
19.7
348
2001
M13.9
ICD-10 Finland
Arthritis, unspecified
2.1
19.5
225
1100
A07EC01
ATC
sulfasalazine; oral, rectal
2.0
19.4
251
1288
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
19.4
259
1345
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
4.0
19.4
78
198
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
19.4
1588
13083
L29.8
ICD-10 Finland
Other pruritus
7.6
19.3
45
60
R51.80
ICD-10 Finland
Headache
1.7
19.2
411
2510
K02.1
ICD-10 Finland
Caries of dentine
1.4
19.1
1712
14311
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
9.8
19.1
38
39
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.6
19.0
601
4076
L28.1
ICD-10 Finland
Prurigo nodularis
55.3
18.9
22
*
M04AA01
ATC
allopurinol; systemic
1.7
18.9
399
2426
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.3
18.8
179
803
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
18.8
474
3034
L01
ICPC
Neck symptom/complaint
1.7
18.7
381
2293
SDA02
NOMESCO Finland
Parodonthologic therapy
1.5
18.6
934
7015
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.2
18.5
199
942
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
18.5
640
4433
D01AE15
ATC
terbinafine; topical
2.1
18.5
220
1090
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
6.3
18.5
49
79
N05CD07
ATC
temazepam; oral
1.8
18.5
367
2192
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
7.5
18.4
43
58
H01.0
ICD-10 Finland
Blepharitis
2.3
18.3
167
733
A06AD11
ATC
lactulose; oral
1.7
18.2
413
2565
D07XB05
ATC
dexamethasone, combinations; topical
3.4
18.1
88
262
SPAT1262
SPAT
Handing over of treatment supplies
1.6
18.1
565
3817
D06BB10
ATC
imiquimod; topical
2.4
18.0
155
662
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.2
18.0
194
922
D01BA02
ATC
terbinafine; oral; topical
1.5
17.8
762
5533
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
17.8
483
3150
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
17.7
1641
13725
D11AH02
ATC
pimecrolimus; topical
+∞
17.7
17
*
69000
ICD-8 Finland
Seborrhoeic dermatitis, Pityriasis simplex sive sicca
+∞
17.7
17
*
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.0
17.7
236
1227
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
17.6
489
3206
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
17.6
323
1877
S04
ICPC
Lump/swelling localized
1.9
17.5
268
1465
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
17.5
283
1578
D07AB01
ATC
clobetasone; topical
3.1
17.5
100
334
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.0
17.5
101
341
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
17.4
448
2878
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
17.4
834
6191
M05BA04
ATC
alendronic acid; oral
2.1
17.4
207
1027
S86
ICPC
Dermatitis seborrhoeic
12.0
17.3
31
26
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
2.4
17.2
154
668
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.9
17.2
244
1297
P01BA02
ATC
hydroxychloroquine; oral
2.0
17.2
225
1159
M01AH05
ATC
etoricoxib; oral
1.4
17.2
1734
14680
J01MA14
ATC
moxifloxacin; systemic
1.9
17.1
272
1506
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
17.0
1122
8836
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
17.0
411
2597
B05DA
ATC
Isotonic solutions
7.3
16.9
40
55
S97
ICPC
Chronic ulcer skin
2.2
16.9
168
769
S76
ICPC
Skin infection other
2.3
16.8
160
718
J05AB01
ATC
aciclovir; systemic
1.5
16.8
565
3883
R05
ICD-10 Finland
Cough
1.6
16.7
531
3599
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
3.7
16.6
72
196
J01MA12
ATC
levofloxacin; systemic
1.5
16.6
554
3798
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
16.5
1400
11493
N48.1
ICD-10 Finland
Balanoposthitis
2.9
16.5
100
347
H02AB07
ATC
prednisone; oral
1.7
16.4
391
2459
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
16.3
280
1593
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
16.3
540
3695
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.4
16.3
971
7499
M79.1
ICD-10 Finland
Myalgia
1.7
16.3
345
2097
N06AB06
ATC
sertraline; oral
1.8
16.2
306
1796
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
2.1
16.2
192
951
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.2
16.2
84
264
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.9
16.2
257
1425
N06AB03
ATC
fluoxetine; oral
1.7
16.2
347
2116
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
16.1
217
1133
R60.0
ICD-10 Finland
Localized oedema
1.8
16.1
308
1816
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.6
16.0
394
2500
L29.0
ICD-10 Finland
Pruritus ani
7.9
16.0
36
46
D06BX02
ATC
ingenol mebutate; topical
4.2
16.0
60
144
C07AA05
ATC
propranolol; systemic
1.5
16.0
525
3586
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
15.8
194
975
R06AX13
ATC
loratadine; oral
1.6
15.8
393
2501
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.5
15.8
125
513
N05CF02
ATC
zolpidem; oral
1.6
15.8
490
3302
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
4.4
15.8
57
132
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
15.8
305
1803
L40.9
ICD-10 Finland
Psoriasis, unspecified
4.1
15.7
61
151
K50.9
ICD-10 Finland
Crohn disease, unspecified
4.1
15.7
61
151
A07EC02
ATC
mesalazine; oral, rectal
2.2
15.7
170
810
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
15.7
447
2946
A07AA02
ATC
nystatin; oral
2.1
15.7
188
935
L23.1
ICD-10 Finland
Allergic contact dermatitis due to adhesives
+∞
15.6
15
*
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
2.1
15.6
170
814
N03AF01
ATC
carbamazepine; oral, rectal
2.2
15.5
159
739
SPAT1254
SPAT
Administration of medicine
1.6
15.5
430
2811
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
6.7
15.5
39
59
R74
ICPC
Upper respiratory infection acute
1.4
15.5
740
5474
D09AB01
ATC
zinc bandage without supplements; topical
4.2
15.4
58
140
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.3
15.3
148
671
S87
ICPC
Dermatitis/atopic eczema
3.9
15.3
62
160
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.0
15.2
204
1061
ZYC01
NOMESCO Finland
Remote contact by phone
2.3
15.2
138
604
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
15.2
256
1446
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.5
15.2
690
5048
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
4.9
15.2
49
101
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.8
15.2
95
340
L40.8
ICD-10 Finland
Other psoriasis
6.6
15.1
38
58
D01AC08
ATC
ketoconazole; topical
3.9
15.0
62
163
M01AE02
ATC
naproxen; oral, rectal
1.3
14.9
1671
14243
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.6
14.9
444
2955
M48.0
ICD-10 Finland
Spinal stenosis
1.7
14.9
332
2049
-1
NOMESCO Finland
NA
1.4
14.9
947
7376
L84
ICD-10 Finland
Corns and callosities
2.6
14.8
108
424
H29
ICPC
Ear symptom/complaint other
1.7
14.7
289
1716
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.3
14.7
135
596
J01FA10
ATC
azithromycin; systemic
1.3
14.7
1679
14344
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
3.6
14.7
65
181
L08
ICPC
Shoulder symptom/complaint
1.5
14.7
523
3632
R21
ICPC
Throat symptom/complaint
1.5
14.7
503
3464
B05DB
ATC
Hypertonic solutions
7.5
14.7
34
46
Z71.8
ICD-10 Finland
Other specified counselling
1.5
14.6
654
4764
69282
ICD-8 Finland
Other eczema and dermatitis, E microbis
+∞
14.6
14
*
N02AA05
ATC
oxycodone; systemic
1.6
14.5
406
2663
S02CA02
ATC
flumetasone and antiinfectives; otic
2.1
14.4
172
858
R35
ICD-10 Finland
Polyuria
2.0
14.3
197
1035
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
14.3
1077
8616
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.9
14.3
228
1263
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
4.3
14.3
52
122
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.0
14.2
177
894
SPAT1325
SPAT
Vaccination
1.4
14.2
1010
8002
XQ899
NOMESCO Finland
Other assessment of skin
9.7
14.2
28
29
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
14.1
450
3042
J31.0
ICD-10 Finland
Chronic rhinitis
1.9
14.0
209
1134
SPAT1240
SPAT
Therapeutic discussion
1.7
14.0
287
1728
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.8
14.0
90
326
A01AB09
ATC
miconazole; local oral
1.8
14.0
238
1351
N06AB05
ATC
paroxetine; oral
2.0
13.9
182
940
L93.0
ICD-10 Finland
Discoid lupus erythematosus
9.4
13.9
28
30
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.9
13.9
219
1210
J01FA01
ATC
erythromycin; systemic
1.6
13.9
369
2384
SPAT1255
SPAT
Intravenous administration of medicine
2.0
13.9
191
1004
L04AB04
ATC
adalimumab; parenteral
3.4
13.9
67
201
L43.8
ICD-10 Finland
Other lichen planus
3.8
13.8
58
155
R52.2
ICD-10 Finland
Other chronic pain
2.6
13.8
99
385
L30.1
ICD-10 Finland
Dyshidrosis [pompholyx]
53.5
13.8
16
*
SPAT1211
SPAT
Application of soft bandage
1.8
13.8
258
1509
M79.7
ICD-10 Finland
Fibromyalgia
2.9
13.8
85
301
M03BX02
ATC
tizanidine; oral
1.3
13.8
1814
15760
R5140
NOMESCO Finland
Monitoring the use of the aid
1.7
13.7
316
1966
T78.4
ICD-10 Finland
Allergy, unspecified
2.4
13.7
114
479
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
13.7
300
1841
D10AF01
ATC
clindamycin; topical
2.2
13.7
144
679
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.1
13.7
160
789
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.5
13.7
561
4012
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.2
13.6
133
605
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
13.6
287
1740
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.2
13.6
143
675
L26
ICD-10 Finland
Exfoliative dermatitis
75.4
13.6
15
*
L24.8
ICD-10 Finland
Irritant contact dermatitis due to other agents
75.4
13.6
15
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
13.6
772
5880
L15
ICPC
Knee symptom/complaint
1.5
13.6
557
3983
N03AX09
ATC
lamotrigine; oral
2.2
13.6
138
642
H60.8
ICD-10 Finland
Other otitis externa
2.7
13.5
92
345
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
+∞
13.5
13
*
KMAK
NOMESCO Finland
NA
1.3
13.5
1490
12608
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
7.2
13.5
32
45
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
13.5
1672
14384
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.6
13.5
100
397
K50.8
ICD-10 Finland
Other Crohn disease
3.7
13.4
58
159
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.9
13.4
207
1137
ZZR00
NOMESCO Finland
Flap of skin
2.8
13.4
87
319
S24
ICPC
Hair/scalp symptom/complaint other
5.0
13.3
42
85
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
7.7
13.3
30
39
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
13.3
345
2218
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
2.8
13.3
84
304
R05
ICPC
Cough
1.5
13.3
592
4302
K59.09
ICD-10 Finland
Constipation, unspecified
2.0
13.3
179
937
A04
ICPC
Weakness/tiredness general
1.6
13.1
346
2231
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
13.1
218
1226
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.1
13.1
142
680
L13
ICPC
Hip symptom/complaint
1.6
13.0
400
2681
L73.2
ICD-10 Finland
Hidradenitis suppurativa
5.1
13.0
40
79
R02
ICPC
Shortness of breath/dyspnoea
1.6
13.0
321
2037
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
2.0
12.9
157
789
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
3.0
12.9
75
257
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.7
12.9
88
332
R03DC03
ATC
montelukast; oral
1.5
12.8
411
2782
Z3229
NOMESCO Finland
Other healthcare associate professional
1.8
12.8
242
1423
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
12.8
588
4302
H60
ICD-10 Finland
Otitis externa
2.1
12.7
135
641
A11CC03
ATC
alfacalcidol; systemic
2.8
12.7
79
282
N06AB10
ATC
escitalopram; oral
1.5
12.7
528
3783
T90
ICPC
Diabetes non-insulin dependent
1.4
12.7
652
4863
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.9
12.7
186
1001
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.7
12.7
283
1743
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.2
12.7
127
587
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.9
12.7
186
1004
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.8
12.7
52
137
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.2
12.6
129
601
H60.3
ICD-10 Finland
Other infective otitis externa
2.9
12.6
75
261
L28.2
ICD-10 Finland
Other prurigo
32.1
12.6
16
5
L40
ICD-10 Finland
Psoriasis
3.2
12.5
64
201
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
12.5
374
2491
6929X
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]
+∞
12.5
12
*
L24.0
ICD-10 Finland
Irritant contact dermatitis due to detergents
+∞
12.5
12
*
C05AA08
ATC
fluocortolone; rectal, topical
1.5
12.5
394
2659
V03AE02
ATC
sevelamer; oral
7.3
12.5
29
40
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.3
12.4
109
473
C07AB07
ATC
bisoprolol; oral
1.3
12.4
1341
11266
R01AD08
ATC
fluticasone; nasal
1.4
12.4
771
5951
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
12.3
222
1286
D01AC03
ATC
econazole; topical
1.9
12.3
181
980
L60.0
ICD-10 Finland
Ingrowing nail
2.2
12.3
126
588
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
12.3
522
3756
ZZA00
NOMESCO Finland
Split skin graft
2.5
12.2
92
369
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.7
12.2
233
1371
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
12.2
773
5984
N05AA02
ATC
levomepromazine; systemic
2.2
12.2
128
604
R4180
NOMESCO Finland
Podiatric therapy
4.4
12.1
43
99
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
4.6
12.1
41
90
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
12.1
1135
9337
Z3231
NOMESCO Finland
Registered nurse
1.4
12.1
785
6097
B35.1
ICD-10 Finland
Tinea unguium
1.9
12.1
169
895
XG410
NOMESCO Finland
Flow-volume spirometry
2.2
12.1
120
553
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
12.1
759
5866
S19
ICPC
Skin injury other
2.2
12.0
119
546
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
6.6
12.0
30
46
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.3
12.0
112
503
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.8
11.9
193
1075
N03AG01
ATC
valproic acid; systemic, rectal
1.9
11.9
174
938
Z01.9
ICD-10 Finland
Special examination, unspecified
2.0
11.9
155
798
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
11.9
285
1795
S88
ICPC
Dermatitis contact/allergic
3.5
11.9
55
161
EBA00
NOMESCO Finland
Extraction of tooth
1.3
11.8
931
7456
N06AX12
ATC
bupropion; oral
1.9
11.8
163
860
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.0
11.8
146
738
F51.0
ICD-10 Finland
Nonorganic insomnia
1.6
11.8
329
2154
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
5.9
11.8
32
55
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.9
11.8
180
985
R03BA02
ATC
budesonide; inhalant
1.5
11.8
445
3124
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
2.5
11.7
89
358
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.8
11.7
212
1229
WZA90
NOMESCO Finland
Other doctors statement
1.4
11.7
636
4788
D01AE16
ATC
amorolfine; topical
1.6
11.7
325
2123
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
11.7
647
4889
J01EA01
ATC
trimethoprim; systemic
1.4
11.7
606
4525
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
11.7
329
2156
M01AH01
ATC
celecoxib; oral (coxibs)
1.5
11.7
478
3409
N06AA12
ATC
doxepin; systemic
2.0
11.7
147
749
J01DA06
ATC
[U] cefuroxime; systemic
1.5
11.7
396
2713
H61.2
ICD-10 Finland
Impacted cerumen
1.9
11.6
161
853
H01
ICPC
Ear pain/earache
1.6
11.6
280
1767
J01XC01
ATC
fusidic acid; systemic
4.1
11.6
44
109
S08
ICPC
Skin colour change
2.1
11.5
133
655
ZXX05
NOMESCO Finland
Extent of procedure, 5 units
11.1
11.5
21
19
H02AB09
ATC
hydrocortisone; systemic
2.7
11.5
76
282
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.7
11.5
249
1524
C01CA24
ATC
epinephrine; parenteral
2.0
11.5
152
788
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.6
11.5
80
307
69091
ICD-8 Finland
NA
+∞
11.5
11
*
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.3
11.5
103
454
D05AX03
ATC
calcitriol; topical
3.5
11.4
52
150
N30.0
ICD-10 Finland
Acute cystitis
1.6
11.4
319
2089
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
2.1
11.4
125
601
ZXA00
NOMESCO Finland
Right side
1.4
11.4
742
5760
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.9
11.4
162
867
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
11.3
222
1318
J04BA02
ATC
dapsone; oral
7.9
11.3
25
32
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.5
11.3
87
354
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
2.9
11.3
68
240
K59.0
ICD-10 Finland
Constipation
2.0
11.3
151
789
205
Kela drug reimbursment
Chronic hypertension
1.4
11.3
781
6121
SPAT1141
SPAT
Excision of skin or mucous membrane lesion
2.1
11.3
126
611
R01AD12
ATC
fluticasone furoate; nasal
1.4
11.2
773
6057
N05BA12
ATC
alprazolam; oral
1.6
11.2
272
1718
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
11.2
265
1660
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.5
11.2
83
332
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
5.3
11.2
33
63
E66.01
ICD-10 Finland
Obesity due to excess calories
1.8
11.2
203
1180
L99
ICPC
Musculoskeletal disease other
3.4
11.1
53
159
L85.89
ICD-10 Finland
Other specified epidermal thickening
20.1
11.1
16
8
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
11.1
642
4884
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
11.1
216
1279
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.7
11.1
256
1593
TK800
NOMESCO Finland
Hemodialysis
2.7
11.1
74
278
K03.66
ICD-10 Finland
Tooth plaque
1.8
11.0
178
993
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.8
11.0
193
1108
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.3
11.0
95
411
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
11.2
11.0
20
18
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.7
11.0
219
1308
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
11.0
1197
10025
J01CF05
ATC
flucloxacillin; systemic
2.2
11.0
113
532
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.1
11.0
115
545
F45.8
ICD-10 Finland
Other somatoform disorders
1.9
10.9
166
908
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.7
10.9
213
1262
L71
ICD-10 Finland
Rosacea
2.9
10.9
64
222
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
10.9
507
3707
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.6
10.9
307
2014
N05AH03
ATC
olanzapine; systemic
1.8
10.9
171
948
L73.9
ICD-10 Finland
Follicular disorder, unspecified
7.8
10.8
24
31
C03DA01
ATC
spironolactone; oral
1.6
10.8
279
1790
UDC00
NOMESCO Finland
Ear microscopy
1.7
10.8
202
1184
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.8
10.8
45
121
WW200
NOMESCO Finland
Immunization
2.5
10.8
86
355
A07EA06
ATC
budesonide; oral, local oral
2.3
10.8
93
402
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
10.8
274
1752
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
1.7
10.8
215
1284
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
10.8
266
1689
A01
ICPC
Pain general/multiple sites
1.8
10.8
192
1107
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
8.8
10.7
22
25
S01
ICPC
Pain/tenderness of skin
2.1
10.7
116
557
L24.9
ICD-10 Finland
Irritant contact dermatitis, unspecified cause
28.1
10.7
14
5
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.8
10.7
175
980
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
10.7
164
902
L43.9
ICD-10 Finland
Lichen planus, unspecified
3.3
10.7
52
159
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.3
10.7
1003
8221
XKD00
NOMESCO Finland
Uroflowmetry
1.4
10.7
501
3667
Z49.1
ICD-10 Finland
Extracorporeal dialysis
3.2
10.6
53
165
C09CA01
ATC
losartan; oral
1.4
10.5
650
4994
SPAT1234
SPAT
Support of social functional capacity
2.0
10.5
136
701
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.3
10.5
93
406
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.5
10.5
332
2238
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
2.5
10.5
78
313
G04CA02
ATC
tamsulosin; oral
1.3
10.4
723
5663
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.6
10.4
257
1628
Z2446
NOMESCO Finland
Social worker
1.8
10.4
176
1000
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.9
10.4
153
827
A98
ICPC
Health maint/preventive medicine
1.5
10.4
3185
30556
WQ021
NOMESCO Finland
NA
16.1
10.3
16
10
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.8
10.3
65
237
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.6
10.3
74
292
C09AA02
ATC
enalapril; systemic
1.4
10.3
540
4037
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
10.3
1015
8370
A07EA02
ATC
hydrocortisone; rectal
2.7
10.2
69
261
H81
ICPC
Excessive ear wax
1.4
10.2
441
3173
K61.0
ICD-10 Finland
Anal abscess
3.1
10.2
55
181
R06AX26
ATC
fexofenadine; oral
1.8
10.2
160
885
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.8
10.2
175
1000
T82
ICPC
Obesity
2.2
10.2
100
461
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.9
10.2
140
740
Z49.2
ICD-10 Finland
Other dialysis
4.9
10.2
32
66
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
10.2
685
5337
K50.1
ICD-10 Finland
Crohn disease of large intestine
3.4
10.1
47
139
L01.0
ICD-10 Finland
Impetigo [any organism] [any site]
3.7
10.1
42
114
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.8
10.0
179
1035
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
10.0
265
1711
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.5
9.9
78
322
SPAT1147
SPAT
Destruction of skin lesion with external methods
2.9
9.9
59
208
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
9.9
667
5198
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
16.7
9.9
15
9
WZC30
NOMESCO Finland
Teaching
1.5
9.8
356
2472
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.5
9.8
326
2220
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.3
9.8
84
364
L91.0
ICD-10 Finland
Hypertrophic scar
3.6
9.8
43
122
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.2
9.8
99
463
S02
ICPC
Pruritus
2.3
9.7
85
368
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.6
9.7
238
1507
SBB10
NOMESCO Finland
Teeth copy
1.8
9.7
167
956
H53.1
ICD-10 Finland
Subjective visual disturbances
1.8
9.7
153
849
M54
ICD-10 Finland
Dorsalgia
1.6
9.7
277
1826
R52.9
ICD-10 Finland
Pain, unspecified
1.6
9.6
224
1401
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.7
9.6
192
1147
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
3.0
9.6
55
187
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.4
9.6
76
316
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.8
9.6
151
839
D82
ICPC
Teeth/gum disease
1.3
9.6
937
7699
K59.1
ICD-10 Finland
Functional diarrhoea
2.0
9.6
125
649
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.5
9.6
75
308
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
9.6
2082
18869
WXQ99
NOMESCO Finland
Other light therapy
11.4
9.5
17
15
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.1
9.5
51
168
S74
ICPC
Dermatophytosis
2.8
9.5
60
218
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.2
9.5
92
421
ZX120
NOMESCO Finland
Intravenous
1.6
9.5
257
1667
XQ820
NOMESCO Finland
Exposure to medicinal substance
9.1
9.5
19
21
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
5.2
9.5
28
54
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.5
9.5
332
2287
R03BA01
ATC
beclometasone; inhalant
1.5
9.5
356
2491
L23
ICD-10 Finland
Allergic contact dermatitis
7.1
9.5
22
31
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.9
9.5
136
729
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
9.5
126
658
WX002
NOMESCO Finland
Sedation and analgesia
1.4
9.5
522
3932
R05FB02
ATC
cough suppressants and expectorants
1.3
9.4
1015
8443
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
9.4
713
5646
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
9.4
795
6397
N03AX14
ATC
levetiracetam; systemic
2.4
9.4
80
342
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
4.1
9.4
35
86
C07AB02
ATC
metoprolol; systemic
1.4
9.4
553
4209
N05AX08
ATC
risperidone; systemic
1.7
9.4
207
1274
Z00.8
ICD-10 Finland
Other general examinations
1.7
9.4
185
1103
N04BC05
ATC
pramipexole; oral
1.7
9.4
181
1071
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.0
9.3
112
561
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
9.3
80
347
J34.2
ICD-10 Finland
Deviated nasal septum
1.8
9.3
154
870
L04AA13
ATC
leflunomide; oral
2.5
9.3
71
290
A28
ICPC
Limited function/disability NOS
1.5
9.3
366
2585
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
9.3
258
1688
A02BC04
ATC
rabeprazole; oral
1.6
9.3
217
1358
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.3
9.3
738
5891
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.8
9.3
148
826
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
3.0
9.2
51
172
M01AX05
ATC
glucosamine; oral
1.4
9.2
484
3610
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.5
9.2
71
292
K51.5
ICD-10 Finland
Left sided colitis
2.3
9.2
82
362
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
4.6
9.2
30
65
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
2.7
9.2
62
235
SPAT1139
SPAT
Nutrition survey
2.2
9.1
90
417
K50.0
ICD-10 Finland
Crohn disease of small intestine
3.1
9.1
48
157
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
3.6
9.1
39
109
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.2
9.1
86
389
P20
ICPC
Memory disturbance
1.5
9.1
291
1968
R03BA05
ATC
fluticasone; inhalant
1.4
9.0
454
3360
WX290
NOMESCO Finland
Other blockade of nerve
1.3
9.0
1203
10273
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
9.0
719
5735
SPAT1053
SPAT
Memory test
1.4
9.0
376
2689
M02AA07
ATC
piroxicam; topical
1.3
9.0
960
7974
L02
ICPC
Back symptom/complaint
1.6
8.9
220
1395
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
6.5
8.9
22
34
S80.0
ICD-10 Finland
Contusion of knee
1.8
8.9
156
898
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.1
8.9
95
454
P03
ICPC
Feeling depressed
1.6
8.9
205
1276
N06AX03
ATC
mianserin; oral
1.9
8.9
128
691
N01
ICPC
Headache
1.6
8.9
241
1567
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.9
8.9
123
652
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
8.9
221
1408
H62.0
ICD-10 Finland
Otitis externa in bacterial diseases classified elsewhere
12.5
8.9
15
12
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
3.3
8.8
43
133
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
8.8
281
1896
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
1.9
8.8
133
729
J05AB11
ATC
valaciclovir; oral
1.5
8.8
321
2232
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
4.9
8.8
27
55
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.6
8.7
243
1591
F10.25
ICD-10 Finland
Alcohol dependence continuous use
2.6
8.7
60
231
7806A
ICD-9 Finland
General symptoms, Pyrexia of unknown origin
4.7
8.7
28
60
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
8.7
740
5957
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
8.7
678
5391
N03AF02
ATC
oxcarbazepine; oral
2.1
8.7
91
432
M02AA10
ATC
ketoprofen; topical
1.4
8.6
403
2946
104
Kela drug reimbursment
Thyroid insufficiency
1.7
8.6
164
971
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.1
8.6
91
437
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.7
8.6
158
923
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
11.6
8.6
15
13
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
4.2
8.6
31
75
ZXD05
NOMESCO Finland
Urgent procedure
1.3
8.5
855
7029
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.5
8.5
254
1688
A03CA02
ATC
clidinium and psycholeptics; oral
1.8
8.5
151
873
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
6.9
8.5
20
29
F41.1
ICD-10 Finland
Generalized anxiety disorder
2.0
8.5
110
569
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.1
8.5
97
478
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
8.5
211
1343
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.3
8.5
72
311
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.6
8.5
58
222
A05
ICPC
Feeling ill
1.8
8.5
147
845
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.6
8.5
59
230
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.1
8.5
95
467
R55
ICD-10 Finland
Syncope and collapse
1.5
8.5
277
1885
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
5.1
8.4
25
49
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.3
8.4
633
5000
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
4.1
8.4
31
76
Z94.4
ICD-10 Finland
Liver transplant status
7.3
8.4
19
26
U02
ICPC
Urinary frequency/urgency
1.5
8.4
288
1977
183
Kela drug reimbursment
Lamotrigin and topiramate
3.9
8.4
33
86
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.8
8.4
150
871
R03BA08
ATC
ciclesonide; inhalant
1.6
8.4
194
1213
C08CA02
ATC
felodipine; oral
1.5
8.4
251
1672
EBA10
NOMESCO Finland
Surgical removal of tooth
1.5
8.4
300
2078
K07
ICPC
Swollen ankles/oedema
2.0
8.3
103
526
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.4
8.3
513
3930
S10
ICPC
Boil/carbuncle
1.8
8.3
144
827
F29
ICPC
Eye symptom/complaint other
1.6
8.3
201
1268
D11AX14
ATC
[U] tacrolimus; topical
+∞
8.3
8
*
69109
ICD-8 Finland
Infantile eczema and related conditions, Unspecified
+∞
8.3
8
*
69299
ICD-8 Finland
Other eczema and dermatitis, Due to other and unspecified cause
+∞
8.3
8
*
69008
ICD-8 Finland
Seborrhoeic dermatitis, Alia definita
+∞
8.3
8
*
6929B
ICD-9 Finland
Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]
+∞
8.3
8
*
M01AX17
ATC
nimesulide; oral
1.3
8.3
637
5043
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
8.3
1076
9130
L53.9
ICD-10 Finland
Erythematous condition, unspecified
3.6
8.3
35
97
L63.9
ICD-10 Finland
Alopecia areata, unspecified
6.2
8.3
21
34
N05BA09
ATC
clobazam; oral
6.2
8.3
21
34
R83
ICPC
Respiratory infection other
1.3
8.3
584
4568
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
5.2
8.3
24
46
TGC00
NOMESCO Finland
Bronchial lavation
2.3
8.3
73
322
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
2.1
8.3
86
409
Z50.1
ICD-10 Finland
Other physical therapy
1.8
8.3
141
805
B03XA02
ATC
darbepoetin alfa; parenteral
2.6
8.2
57
221
L40.5
ICD-10 Finland
Arthropathic psoriasis
2.7
8.2
53
197
R31
ICD-10 Finland
Unspecified haematuria
1.5
8.2
274
1869
M01AC06
ATC
meloxicam; systemic, rectal
1.3
8.2
974
8177
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.8
8.2
144
829
G04BD12
ATC
mirabegron; oral
1.5
8.2
253
1697
R07.0
ICD-10 Finland
Pain in throat
1.8
8.2
144
831
C08CA01
ATC
amlodipine; oral
1.3
8.2
947
7925
QXA05
NOMESCO Finland
Skin division, unspecified location
6.5
8.2
20
31
M10.9
ICD-10 Finland
Gout, unspecified
1.7
8.2
180
1110
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
8.2
324
2294
B37.2
ICD-10 Finland
Candidiasis of skin and nail
4.5
8.2
27
60
N18.0
ICD-10 Finland
End-stage renal disease
3.2
8.1
41
131
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.4
8.1
433
3237
U07
ICPC
Urine symptom/complaint other
1.8
8.1
138
788
C09CA06
ATC
candesartan; oral
1.3
8.1
544
4226
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
8.1
593
4666
K07.60
ICD-10 Finland
Snapping jaw
1.9
8.1
113
604
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.4
8.1
67
288
L64.8
ICD-10 Finland
Other androgenic alopecia
33.4
8.1
10
*
L88
ICPC
Rheumatoid/seropositive arthritis
2.1
8.1
89
433
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
6.8
8.0
19
28
D01
ICPC
Abdominal pain/cramps general
1.5
8.0
247
1656
R03BB04
ATC
tiotropium bromide; inhalant
1.5
8.0
257
1737
B35.4
ICD-10 Finland
Tinea corporis
3.6
8.0
34
95
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
3.6
8.0
34
95
L50.9
ICD-10 Finland
Urticaria, unspecified
2.1
8.0
84
400
WQ007
NOMESCO Finland
NA
22.1
8.0
11
5
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.6
8.0
204
1309
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.7
8.0
52
196
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.8
7.9
129
725
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.6
7.9
222
1458
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.2
7.9
76
349
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.2
7.9
78
361
M01AH02
ATC
rofecoxib; oral
1.4
7.9
329
2353
V03AE01
ATC
polystyrene sulfonate; oral
3.1
7.9
41
134
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.8
7.9
140
813
-
ICD-10 Finland
NA
2.3
7.9
70
309
H16.0
ICD-10 Finland
Corneal ulcer
1.8
7.9
125
700
M45
ICD-10 Finland
Ankylosing spondylitis
2.4
7.8
65
279
L29.2
ICD-10 Finland
Pruritus vulvae
5.1
7.8
23
45
C05AA01
ATC
hydrocortisone; rectal, topical
1.7
7.8
141
820
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
7.8
279
1932
D01AA02
ATC
natamycin; topical
2.5
7.8
59
242
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.7
7.8
141
822
K05.31
ICD-10 Finland
Periodontitis pronounced
1.5
7.8
250
1692
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.9
7.8
101
527
K08.3
ICD-10 Finland
Retained dental root
1.6
7.8
186
1173
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.7
7.8
139
808
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
2.4
7.8
61
254
M54.6
ICD-10 Finland
Pain in thoracic spine
1.7
7.8
158
954
H62.0*A46
ICD-10 Finland
Otitis externa in erysipelas
4.1
7.8
28
68
ZX108
NOMESCO Finland
Inhalation
4.1
7.8
28
68
S22.3
ICD-10 Finland
Fracture of rib
1.6
7.7
176
1097
N18.8
ICD-10 Finland
Other chronic renal failure
2.1
7.7
80
381
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1.9
7.7
106
563
N02AC04
ATC
dextropropoxyphene; oral
1.9
7.7
102
535
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.6
7.7
210
1368
M10.0
ICD-10 Finland
Idiopathic gout
2.0
7.7
87
430
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.6
7.7
185
1168
S01GX08
ATC
ketotifen; ophthalmic
2.1
7.7
80
382
K30
ICD-10 Finland
Functional dyspepsia
1.5
7.7
249
1691
S06.0
ICD-10 Finland
Concussion
1.5
7.7
253
1721
J20
ICD-10 Finland
Acute bronchitis
1.5
7.7
228
1517
SPAT1360
SPAT
Extensive global examination
1.6
7.7
193
1235
R20.2
ICD-10 Finland
Paraesthesia of skin
1.7
7.7
155
932
A03
ICPC
Fever
1.4
7.7
386
2857
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.6
7.6
195
1251
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.2
7.6
69
310
ZXD10
NOMESCO Finland
Scheduled procedure
1.2
7.6
1035
8817
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.8
7.6
126
713
WQ020
NOMESCO Finland
NA
18.4
7.6
11
6
L27.2
ICD-10 Finland
Dermatitis due to ingested food
25.0
7.6
10
*
M50.3
ICD-10 Finland
Other cervical disc degeneration
2.3
7.6
65
282
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.5
7.5
228
1523
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
8.9
7.5
15
17
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.4
7.5
59
245
U04
ICPC
Incontinence urine
1.9
7.5
107
578
L27.1
ICD-10 Finland
Localized skin eruption due to drugs and medicaments
10.0
7.5
14
14
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.8
7.5
126
719
K90.0
ICD-10 Finland
Coeliac disease
2.1
7.5
76
359
R33
ICD-10 Finland
Retention of urine
1.5
7.5
214
1413
SPAT1252
SPAT
Overall medication plan or its review
1.6
7.5
175
1100
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.1
7.5
78
373
A01AB04
ATC
amphotericin B; local oral
1.8
7.5
118
661
H10
ICD-10 Finland
Conjunctivitis
1.7
7.5
143
850
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.4
7.4
59
248
N06AX26
ATC
vortioxetine; oral
1.7
7.4
139
818
XKC03
NOMESCO Finland
Water cystometry
2.1
7.4
82
402
H60.1
ICD-10 Finland
Cellulitis of external ear
3.1
7.4
38
124
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.3
7.4
64
280
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.0
7.4
93
480
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
1.8
7.4
117
656
N05AB03
ATC
perphenazine; systemic, rectal
2.0
7.3
93
481
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.4
7.3
61
262
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.6
7.3
178
1128
H02
ICPC
Hearing complaint
1.4
7.3
298
2123
E66.8
ICD-10 Finland
Other obesity
1.8
7.3
122
695
70630
ICD-8 Finland
Diseases of sebaceous glands, Seborrhoea
+∞
7.3
7
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.2
7.3
70
324
A10BA02
ATC
metformin; oral
1.3
7.3
746
6139
J01CE08
ATC
benzathine benzylpenicillin; parenteral
3.2
7.3
35
109
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.5
7.3
232
1570
B03XA01
ATC
erythropoietin; parenteral
3.6
7.2
30
83
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.6
7.2
171
1078
F41.8
ICD-10 Finland
Other specified anxiety disorders
2.3
7.2
63
276
B03BA03
ATC
hydroxocobalamin; parenteral
1.7
7.2
139
828
R32
ICD-10 Finland
Unspecified urinary incontinence
2.3
7.2
64
286
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.6
7.2
48
185
KGB00
NOMESCO Finland
Biopsy of penis
7.3
7.2
16
22
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.7
7.2
157
968
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.9
7.2
96
508
N05BA02
ATC
chlordiazepoxide; systemic
2.2
7.2
68
311
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
3.5
7.2
31
89
B02.9
ICD-10 Finland
Zoster without complication
1.7
7.2
135
799
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.8
7.2
119
678
R29
ICPC
Respiratory symptom/complaint other
1.7
7.1
150
913
XQ817
NOMESCO Finland
NA
30.1
7.1
9
*
J30.3
ICD-10 Finland
Other allergic rhinitis
2.1
7.1
80
393
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.8
7.1
115
648
F33.01
ICD-10 Finland
Recurrent depression, mild episode of somatic syndrome
4.8
7.1
22
46
L50.8
ICD-10 Finland
Other urticaria
2.6
7.1
48
186
M03BX01
ATC
baclofen; systemic
2.4
7.1
54
223
J01MA01
ATC
ofloxacin; systemic
1.5
7.1
223
1506
N87
ICPC
Parkinsonism
2.9
7.1
41
143
C08CA13
ATC
lercanidipine; oral
1.4
7.1
317
2299
K04.0
ICD-10 Finland
Pulpitis
1.5
7.1
236
1614
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
5.3
7.1
20
38
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.6
7.1
183
1180
SPAT1059
SPAT
Spirometry at the office
1.7
7.0
134
795
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
3.6
7.0
29
80
L16
ICPC
Ankle symptom/complaint
1.5
7.0
241
1654
E66.00
ICD-10 Finland
Metabolic syndrome
1.7
7.0
137
816
P29
ICPC
Psychological sympt/compl other
1.7
7.0
127
743
A29
ICPC
General symptom/complaint other
1.5
7.0
269
1891
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.4
7.0
298
2137
SPAT1202
SPAT
Intra-articular injection
2.1
7.0
77
377
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.9
7.0
96
510
A10AE04
ATC
insulin glargine; parenteral
1.5
7.0
249
1728
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.6
7.0
163
1023
N48.8
ICD-10 Finland
Other specified disorders of penis
4.0
7.0
26
66
N17
ICPC
Vertigo/dizziness
1.5
7.0
257
1793
N05AL01
ATC
sulpiride; systemic
2.7
6.9
45
169
SPAT1081
SPAT
Cardiorespiratory global assessment
1.7
6.9
148
905
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.2
6.9
65
298
S02CA06
ATC
dexamethasone and antiinfectives; otic
3.7
6.9
28
76
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
3.3
6.9
32
97
H26.3
ICD-10 Finland
Drug-induced cataract
5.2
6.9
20
39
R03AC03
ATC
terbutaline; inhalant
1.4
6.9
329
2411
N06AA06
ATC
trimipramine; systemic
2.3
6.9
59
259
XQ801
NOMESCO Finland
Intracutantest
5.8
6.9
18
31
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
2.5
6.9
49
195
N06AX17
ATC
milnacipran; oral
3.1
6.9
35
114
G20
ICD-10 Finland
Parkinson disease
2.0
6.9
83
423
L08.0
ICD-10 Finland
Pyoderma
4.1
6.9
25
62
S99
ICPC
Skin disease other
2.5
6.9
52
214
A06AC51
ATC
ispaghula, combinations; systemic
1.8
6.8
116
664
J01FA09
ATC
clarithromycin; systemic
1.3
6.8
822
6890
H04
ICPC
Ear discharge
1.9
6.8
91
481
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
1.9
6.8
87
453
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
6.8
196
1298
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
2.5
6.8
49
197
R07.3
ICD-10 Finland
Other chest pain
1.5
6.8
232
1594
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.6
6.8
158
993
K10.3
ICD-10 Finland
Alveolitis of jaws
1.8
6.8
108
607
R06AE08
ATC
NA
3.5
6.8
29
83
P99
ICPC
Psychological disorders other
2.1
6.8
68
321
L66.1
ICD-10 Finland
Lichen planopilaris
40.1
6.8
8
*
F27
ICPC
Fear of eye disease
3.6
6.8
28
78
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
6.8
496
3897
XJH00
NOMESCO Finland
Transanal ultrasonography
1.5
6.7
189
1243
Z94.1
ICD-10 Finland
Heart transplant status
5.6
6.7
18
32
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
16.7
6.7
10
6
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
2.8
6.7
41
150
B01AB05
ATC
enoxaparin; parenteral
1.3
6.7
788
6582
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.8
6.7
40
144
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
4.3
6.7
23
54
D69.0
ICD-10 Finland
Allergic purpura
4.7
6.7
21
45
C02AC05
ATC
moxonidine; oral
1.8
6.7
115
663
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.4
6.7
355
2651
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.1
6.7
73
358
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.0
6.7
75
372
M31.0
ICD-10 Finland
Hypersensitivity angiitis
22.5
6.7
9
*
R01AD11
ATC
triamcinolone; nasal
1.5
6.7
215
1461
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.8
6.7
109
618
K08.80
ICD-10 Finland
Toothache NOS
1.6
6.7
185
1214
C10AA03
ATC
pravastatin; oral
1.6
6.7
177
1147
F34.1
ICD-10 Finland
Dysthymia
1.9
6.7
87
454
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.0
6.7
75
373
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
4.9
6.6
20
41
Z49.0
ICD-10 Finland
Preparatory care for dialysis
3.1
6.6
33
106
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
2.1
6.6
74
364
L63.8
ICD-10 Finland
Other alopecia areata
6.4
6.6
16
25
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
2.3
6.6
59
263
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
4.2
6.6
23
55
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
6.6
306
2235
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.7
6.6
119
695
WX199
NOMESCO Finland
Other local analgesia
2.1
6.6
65
306
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
6.6
1298
11462
C10AA05
ATC
atorvastatin; oral
1.2
6.6
1038
8960
SPAT1104
SPAT
Monitoring of emergency patient
1.6
6.5
170
1099
K51.8
ICD-10 Finland
Other ulcerative colitis
2.6
6.5
44
171
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
6.5
714
5913
NH1CM
NOMESCO Finland
Ankle and foot extensive MRI examination with 3 Tesla magnet
10.0
6.5
12
12
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.5
6.5
233
1616
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.6
6.5
43
165
SPAT1097
SPAT
Recording of ECG
1.4
6.5
374
2831
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
6.5
76
384
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.7
6.5
122
724
N05AX12
ATC
aripiprazole; systemic
1.8
6.5
96
527
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.8
6.5
39
142
R49.08
ICD-10 Finland
Other specified dysphonia
2.3
6.5
56
248
XKD06
NOMESCO Finland
Physiologic investigation of micturition
1.9
6.5
82
427
L13.0
ICD-10 Finland
Dermatitis herpetiformis
6.2
6.5
16
26
L70.9
ICD-10 Finland
Acne, unspecified
5.3
6.4
18
34
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.5
6.4
193
1288
G03HB01
ATC
cyproterone and estrogen; systemic
1.5
6.4
190
1265
WQ031
NOMESCO Finland
NA
70.0
6.4
7
*
B36.0
ICD-10 Finland
Pityriasis versicolor
2.9
6.4
37
129
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.6
6.4
162
1037
ZXA05
NOMESCO Finland
Left side
1.3
6.4
656
5387
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.3
6.4
53
230
R11
ICD-10 Finland
Nausea and vomiting
1.5
6.4
185
1224
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.7
6.4
136
832
VALMI
NOMESCO Finland
NA
1.3
6.4
630
5151
EKA10
NOMESCO Finland
Biopsy of cheek
2.3
6.4
55
242
WX204
NOMESCO Finland
Axillary plexus blockaced
2.0
6.4
79
406
XG466
NOMESCO Finland
Sleep oxymetry
1.9
6.4
87
463
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.5
6.4
180
1185
J45.8
ICD-10 Finland
Mixed asthma
2.1
6.4
70
344
UJD02
NOMESCO Finland
Gastroscopy
1.7
6.3
119
706
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.3
6.3
55
244
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
2.1
6.3
63
298
KGH10
NOMESCO Finland
Operation for phimosis
2.0
6.3
76
385
K05.08
ICD-10 Finland
Another acute gingivitis
2.2
6.3
57
256
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
1.9
6.3
87
467
S82
ICPC
Naevus/mole
1.4
6.3
286
2081
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
5.9
6.3
16
27
D21
ICPC
Swallowing problem
2.8
6.3
38
139
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
3.2
6.3
30
94
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
9.3
6.3
12
13
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
3.6
6.3
26
73
F01
ICPC
Eye pain
2.1
6.3
67
326
C10AA04
ATC
fluvastatin; oral
1.5
6.2
204
1391
G04BD08
ATC
solifenacin; oral
1.6
6.2
154
983
S01.0
ICD-10 Finland
Open wound of scalp
1.5
6.2
192
1291
M01AB05
ATC
diclofenac; systemic, rectal
1.2
6.2
1912
17567
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
3.0
6.2
32
106
SPAT1307
SPAT
Psychosocial counselling and guidance
1.7
6.2
131
802
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.2
6.2
59
272
E000004
ATC
NA
2.5
6.2
44
174
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
2.5
6.2
45
183
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.4
6.2
246
1747
N04BD01
ATC
selegiline; oral
2.6
6.2
42
165
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.2
6.2
57
261
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.5
6.2
219
1520
W10
ICD-10 Finland
Fall on and from stairs and steps
1.7
6.2
117
696
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.5
6.2
230
1610
H70
ICPC
Otitis externa
2.3
6.1
53
233
C08CA05
ATC
nifedipine; systemic
1.6
6.1
167
1092
L05
ICPC
Flank/axilla symptom/complaint
1.6
6.1
132
813
S01GX05
ATC
lodoxamide; ophthalmic
3.0
6.1
32
107
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
1.7
6.1
113
664
N48.4
ICD-10 Finland
Impotence of organic origin
2.2
6.1
59
275
S01GX02
ATC
levocabastine; ophthalmic
1.6
6.1
135
835
A02BA03
ATC
famotidine; systemic
1.8
6.1
97
546
DFF00
NOMESCO Finland
Pure tone audiometry
1.5
6.1
224
1565
H92.0
ICD-10 Finland
Otalgia
1.7
6.1
113
667
S17
ICPC
Abrasion/scratch/blister
2.2
6.1
56
255
R06AX18
ATC
acrivastine; oral
2.2
6.1
59
276
A41.9
ICD-10 Finland
Sepsis, unspecified
1.8
6.1
91
502
G04BD07
ATC
tolterodine; oral
1.7
6.1
111
651
PAW37
NOMESCO Finland
Biopsy of temporal artery
4.0
6.1
22
55
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
6.1
154
991
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
3.7
6.1
24
65
TAB00
NOMESCO Finland
Lumbar puncture
1.8
6.1
102
586
A10BH01
ATC
sitagliptin; oral
1.4
6.1
233
1642
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
3.1
6.0
30
97
NDU20
NOMESCO Finland
Removal of internal fixation device from wrist or hand
2.3
6.0
53
237
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
6.0
332
2496
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
6.0
252
1804
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.1
6.0
65
317
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.7
6.0
109
641
I84.5
ICD-10 Finland
External hemorrhoids without complication
2.0
6.0
72
367
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.7
6.0
126
772
D11
ICPC
Diarrhoea
1.4
6.0
245
1745
K11.2
ICD-10 Finland
Sialoadenitis
2.0
6.0
70
354
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768443) Skin Pathology biopsy report
427
971
4.81
175.70
1.3
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
2280
15887
2.04
100.22
8.3
5.9
e9/l
0.2
0.2
0.74
2069
13920
(3006315) Basophils [#/volume] in Blood
2223
15355
2.04
100.07
8.1
5.7
e9/l
0.0
0.0
0.50
2014
13236
(3001604) Monocytes [#/volume] in Blood
2208
15282
2.02
98.02
8.0
5.7
e9/l
0.6
0.6
0.67
2001
13172
(3019198) Lymphocytes [#/volume] in Blood
2247
15759
2.00
94.74
8.1
5.7
e9/l
1.9
1.9
0.53
2054
13850
(3013707) Erythrocyte sedimentation rate by Westergren method
2935
22808
2.15
91.28
5.7
3.9
mm/h
12.8
11.7
3.28
2724
21103
(3000494) Fungus identified in Specimen by Culture
727
3396
2.40
88.58
1.6
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
2424
17756
1.96
86.54
11.3
8.9
e9/l
4.0
4.2
1.66
2198
15454
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2990
23857
2.08
79.93
10.2
7.4
u/l
78.6
78.4
0.07
2845
22497
(3007853) Bacteria identified in Skin by Aerobe culture
694
3418
2.25
73.57
2.1
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1756
12053
1.83
71.48
2.7
2.2
nmol/l
75.8
76.4
0.41
1619
10837
(3006504) Eosinophils/100 leukocytes in Blood
2013
14409
1.82
71.26
8.4
5.9
%
2.9
2.8
0.61
1882
13404
(3019069) Monocytes/100 leukocytes in Blood
2017
14484
1.81
70.28
8.8
6.2
%
8.7
8.7
0.27
1896
13554
(3022096) Basophils/100 leukocytes in Blood
1958
13993
1.80
68.79
8.5
6.0
%
0.7
0.7
0.55
1839
13052
(3018010) Neutrophils/100 leukocytes in Blood
2025
14669
1.79
67.46
8.0
5.8
%
56.9
57.3
0.89
1896
13714
(3024561) Albumin [Mass/volume] in Serum or Plasma
1860
13150
1.79
67.24
6.6
5.0
g/l
35.3
35.5
0.76
1733
12231
(3002030) Lymphocytes/100 leukocytes in Blood
2046
14905
1.78
66.49
8.5
6.0
%
28.1
27.8
0.75
1918
13877
(3005322) IgE [Units/volume] in Serum or Plasma
393
1579
2.66
64.82
1.3
1.3
u/ml
174.4
156.7
0.20
357
1451
(3037522) Nuclear Ab [Titer] in Serum
725
3879
2.07
61.15
1.5
1.3
titre
464.8
505.4
0.30
168
778
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2047
15202
1.73
59.55
9.0
6.8
mmol/l
1.2
1.2
0.48
1746
12856
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
76
90
8.59
59.30
1.6
1.4
u/ml
13.8
22.1
1.06
12
25
(42870588) Differential panel, method unspecified - Blood
1521
10412
1.75
59.17
8.1
5.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2642
21179
1.76
57.36
5.8
4.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1715
12241
1.71
56.71
2.4
2.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1412
9559
1.75
56.46
3.4
2.5
u/l
54.1
58.0
3.39
1308
8821
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1371
9292
1.73
54.03
2.7
2.1
u/l
214.8
257.3
0.71
1286
8753
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2100
15990
1.68
53.21
7.6
6.2
umol/l
11.4
11.8
0.90
1991
15202
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2806
23234
1.74
50.45
4.4
3.7
pmol/l
14.8
14.8
0.84
2558
21119
(40760892) CBC W Ordered Manual Differential panel - Blood
1057
6760
1.77
50.42
6.6
4.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
2498
20083
1.68
49.76
5.6
4.2
e6/l
568.5
1802.1
1.22
26
312
(3010375) cycloSPORINE [Mass/volume] in Blood
81
129
6.39
48.68
26.3
27.0
ug/l
100.2
124.4
2.33
69
105
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1845
13790
1.64
48.56
8.0
6.0
mmol/l
1.2
1.2
0.29
1680
12511
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1692
12376
1.65
48.54
2.1
1.9
pmol/l
93.1
94.6
0.66
948
6652
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3242
28282
1.86
45.40
5.4
4.4
mu/l
2.6
2.1
0.36
2999
25883
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
58
72
8.16
43.55
1.3
1.4
titre
73.3
48.0
—
6
5
(3019309) Folate [Moles/volume] in Red Blood Cells
881
5583
1.75
42.27
1.9
1.7
nmol/l
1254.8
1164.0
1.79
683
4220
(3036481) Cortisol [Moles/volume] in Serum or Plasma
506
2695
2.01
42.04
2.5
2.1
nmol/l
363.2
371.1
0.40
466
2466
(3015171) Extractable nuclear Ab [Units/volume] in Serum
252
1009
2.60
41.44
1.4
1.2
u/ml
1.3
0.9
0.15
23
95
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1133
7724
1.66
41.27
2.6
2.2
mg/l
2.9
2.9
0.06
979
6590
(3013826) Glucose [Moles/volume] in Serum or Plasma
2284
18426
1.58
40.56
6.3
4.7
mmol/l
6.8
6.8
0.11
2155
17269
(3026493) Urate [Moles/volume] in Serum or Plasma
1195
8301
1.63
40.19
3.5
2.7
umol/l
4015.2
5119.7
0.43
1036
7207
(3023368) Bacteria identified in Blood by Culture
1208
8448
1.62
39.37
5.1
4.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1921
14970
1.56
39.20
6.3
4.6
estimate
0.0
0.0
0.50
423
2860
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
974
6466
1.67
38.93
1.8
1.7
pmol/l
37343785.2
32597822.7
0.07
798
5390
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1239
8740
1.61
38.86
3.4
3.0
ng/l
1678.7
1456.1
0.54
1042
7465
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3491
31560
2.00
38.79
21.5
13.7
mg/l
21.9
24.6
4.66
2947
24884
(3035350) Ketones [Presence] in Urine by Test strip
1919
14990
1.55
38.47
4.8
3.4
estimate
0.0
0.0
1.08
400
2783
(3003458) Phosphate [Moles/volume] in Serum or Plasma
679
4090
1.80
38.40
9.0
6.1
mmol/l
1.1
1.0
0.51
640
3818
(3048689) Calprotectin [Mass/mass] in Stool
601
3496
1.85
38.08
3.1
2.3
ug/g
139.1
142.4
0.07
484
2765
(3009261) Glucose [Presence] in Urine by Test strip
1933
15172
1.54
37.58
4.9
3.4
estimate
0.0
0.0
1.23
398
2740
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
788
5000
1.72
37.03
2.2
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1701
13011
1.54
37.00
3.5
2.8
ug/l
151.2
138.3
0.81
1583
12027
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1568
11791
1.55
36.78
4.4
3.5
ng/l
71.4
53.9
0.20
1120
8124
(3015736) pH of Urine
1545
11583
1.55
36.72
4.4
3.2
—
5.8
—
0
12
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
949
6346
1.65
36.52
1.4
1.3
u/ml
1.5
1.8
0.51
262
1650
(3022948) Iron [Moles/volume] in Serum or Plasma
765
4857
1.72
35.73
3.0
2.5
umol/l
12.6
13.2
1.73
718
4515
(3032080) INR in Blood by Coagulation assay
1653
12704
1.52
34.34
10.7
9.5
inr
1.2
1.3
0.74
478
3682
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
762
4898
1.69
33.79
1.3
1.2
iu/ml
37.0
33.2
0.23
211
1521
(3042936) Bacteria identified in Isolate by Culture
689
4318
1.72
33.52
2.3
2.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
446
2459
1.92
33.11
5.4
4.1
%
0.1
0.1
0.34
124
678
(3017181) Myelocytes/100 leukocytes in Blood
461
2589
1.89
32.31
5.4
4.0
%
0.8
0.9
0.65
130
728
(3007164) IgA [Mass/volume] in Serum or Plasma
849
5680
1.63
32.02
1.7
1.5
g/l
2.6
2.5
0.68
546
3514
(40761535) Cells panel - Urine sediment
447
2495
1.89
31.91
4.5
3.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1523
11641
1.51
31.71
5.3
3.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
498
2885
1.83
31.59
11.1
7.5
mmol/l
10.0
10.0
0.03
477
2748
(3015377) Calcium [Moles/volume] in Serum or Plasma
1352
10089
1.52
31.52
3.5
3.4
mmol/l
2.3
2.3
0.48
1168
8872
(3019550) Sodium [Moles/volume] in Serum or Plasma
3527
32399
1.91
31.42
22.8
15.9
mmol/l
139.6
139.7
2.18
3449
31583
(3023103) Potassium [Moles/volume] in Serum or Plasma
3533
32496
1.91
31.00
22.9
16.1
mmol/l
4.0
4.0
0.20
3450
31630
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2475
20949
1.50
30.52
4.2
3.1
u/l
57.6
49.5
2.91
2327
19565
(3021960) Folate [Moles/volume] in Serum or Plasma
1001
7034
1.57
30.50
1.6
1.5
nmol/l
19.3
20.1
0.94
849
6023
(3002179) Metamyelocytes/100 leukocytes in Blood
422
2353
1.89
30.15
5.1
3.8
%
0.9
0.6
0.44
100
525
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
391
2141
1.92
29.50
1.9
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
695
4506
1.66
29.40
3.0
2.4
g/l
2.3
2.3
0.08
642
4185
(3029937) Albumin [Presence] in Urine by Test strip
1123
8170
1.53
28.97
5.7
3.7
estimate
0.0
0.0
0.06
404
2713
(3025159) Blasts/100 leukocytes in Blood
413
2326
1.87
28.54
5.5
4.1
%
0.0
0.1
1.11
104
568
(3000850) Epithelial cells [#/volume] in Urine
939
6608
1.55
28.05
3.4
2.6
e6/l
4.1
5.0
1.63
828
5798
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
702
4626
1.63
27.69
1.3
1.2
u/ml
3.9
12.6
4.99
265
1818
(3005719) IgG [Mass/volume] in Serum or Plasma
407
2307
1.85
27.52
3.4
2.6
g/l
10.6
10.6
0.05
370
2105
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
649
4211
1.65
27.18
3.2
2.5
%
22.1
23.3
1.39
545
3616
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
188
804
2.41
26.82
1.9
1.6
g/l
1.2
1.2
0.43
181
762
(3026008) Bacteria identified in Urine by Culture
1150
8520
1.50
26.77
3.8
3.0
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
191
831
2.37
26.21
2.4
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
588
3765
1.66
25.83
9.7
6.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
201
901
2.30
25.76
1.7
1.6
iu/ml
44.8
10.7
0.34
47
187
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
159
641
2.54
25.75
7.7
5.9
iu/ml
379.7
3199.3
0.61
25
91
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3184
28807
1.57
25.46
7.1
5.7
mmol/mol
40.2
39.9
0.94
2944
26713
(3028026) IgM [Mass/volume] in Serum or Plasma
329
1807
1.90
24.47
2.0
1.9
g/l
1.5
1.3
0.35
291
1654
(3018418) pH of Serum or Plasma
1178
8895
1.46
24.46
5.9
4.0
ph
7.4
7.4
0.60
256
1734
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
378
2170
1.82
24.44
4.9
4.0
ng/l
101.7
91.1
0.88
328
1882
(3021589) Normoblasts [#/volume] in Blood
1705
13786
1.42
24.39
12.9
9.4
e9/l
0.0
0.0
0.03
1478
11278
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3600
33705
1.87
24.23
14.7
9.9
u/l
27.5
27.4
0.19
3490
32499
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
176
775
2.33
23.51
2.0
1.6
g/l
0.2
0.2
3.95
168
738
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1319
10233
1.44
23.50
4.0
3.3
u/l
34.5
36.9
0.43
1239
9709
(3019225) pH of Specimen
485
3025
1.69
23.41
5.1
4.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
624
4148
1.60
23.39
1.3
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
99
327
3.08
23.36
1.5
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
56
125
4.53
23.33
1.4
1.8
ug/l
6.5
10.8
1.41
51
108
(3009508) Creatinine [Moles/volume] in Urine
1284
9925
1.44
23.29
3.8
3.3
mmol/l
7.9
7.9
0.10
1079
8372
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
358
2060
1.81
22.93
5.2
4.1
kpa
5.2
5.1
1.17
322
1903
(3022217) INR in Platelet poor plasma by Coagulation assay
624
4170
1.59
22.83
26.8
25.0
inr
1.3
1.4
0.54
125
602
(3009343) pH of Capillary blood
353
2027
1.82
22.76
5.2
4.1
ph
7.4
7.4
0.08
39
232
(3012095) Magnesium [Moles/volume] in Serum or Plasma
733
5085
1.54
22.75
4.6
3.5
mmol/l
0.8
0.8
2.24
682
4786
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
448
2758
1.71
22.67
2.6
2.3
ug/l
6.1
8.0
1.34
395
2445
(3023520) Reticulocytes [#/volume] in Blood
431
2629
1.72
22.55
2.6
2.5
e9/l
73.1
69.9
0.84
342
1985
(3013512) EKG study
1173
8965
1.44
22.44
4.6
3.8
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
905
6585
1.49
22.34
5.1
3.8
kg/l
1.0
1.0
0.45
120
993
(3017143) Hepatitis C virus Ab [Presence] in Serum
539
3494
1.63
22.33
1.9
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
546
3559
1.62
22.11
2.6
2.6
%
1.8
1.8
0.23
479
3157
(3020682) Albumin/Creatinine [Ratio] in Urine
1252
9727
1.42
21.73
4.7
4.0
mg/mmol
11.5
9.0
1.01
858
6322
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3291
30299
1.55
21.18
5.5
4.5
mmol/l
6.0
6.0
2.41
3022
27660
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
244
1276
1.97
20.96
2.2
1.9
ug/l
1.1
2.8
2.06
207
1132
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
124
491
2.58
20.88
4.4
3.1
u/ml
254.9
1971.3
—
9
32
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
336
1950
1.79
20.87
5.3
4.1
mmol/l
1.4
1.8
0.88
264
1418
(3018095) Leukocytes [#/volume] in Urine
1391
11078
1.40
20.68
4.6
3.7
e6/l
67.4
101.6
1.13
1094
7884
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
140
593
2.41
20.44
5.0
3.5
%
59.0
58.0
0.45
140
593
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
245
1298
1.95
20.26
2.4
1.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
906
6706
1.46
20.20
2.0
1.7
mg/l
1.1
1.3
0.52
695
5103
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
539
3576
1.59
20.16
4.5
4.0
u/l
235.1
242.2
0.54
504
3392
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
228
1183
1.98
20.03
2.2
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
512
3362
1.60
19.99
1.4
1.3
—
—
—
0
0
(4010399)
349
2074
1.75
19.97
1.5
1.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
131
545
2.45
19.90
1.5
1.2
u/ml
7.1
7.0
0.01
12
45
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3241
29848
1.50
19.71
4.7
3.9
mmol/l
1.4
1.3
5.18
2974
27433
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
203
1027
2.03
19.15
2.9
2.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
458
2968
1.62
18.83
4.5
4.1
mmol/l
2.0
1.9
0.04
372
2376
(3012516) Albumin [Mass/volume] in Urine
1179
9247
1.39
18.76
3.8
3.3
mg/l
262.6
281.0
0.06
813
5986
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1752
14643
1.36
18.72
4.9
4.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
514
3436
1.57
18.52
2.1
1.8
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
158
736
2.20
18.50
1.5
1.2
u/ml
52.0
42.3
0.16
11
42
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
43
94
4.61
18.42
4.4
2.9
mg/l
7.6
8.3
0.30
36
78
(3022313) Gas panel - Capillary blood
266
1493
1.84
18.42
5.5
4.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
512
3425
1.57
18.39
2.0
1.7
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
198
1009
2.01
18.31
1.9
1.6
titre
444.4
287.6
—
9
37
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3338
31067
1.51
17.90
5.2
4.3
mmol/l
4.5
4.6
6.51
3098
28892
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
271
1545
1.81
17.83
2.5
2.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3387
31627
1.53
17.80
5.6
4.8
mmol/l
2.7
2.7
4.57
3119
29241
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3318
30855
1.50
17.73
5.1
4.3
mmol/l
1.4
1.4
5.46
3055
28540
(40761511) CBC panel - Blood by Automated count
3501
32945
1.60
17.68
19.8
12.9
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
94
353
2.70
17.64
1.5
1.4
u/l
21.1
25.7
0.81
78
288
(3021447) Carbon dioxide [Partial pressure] in Venous blood
453
2973
1.59
17.62
4.5
4.1
kpa
5.9
5.8
1.27
439
2882
(3030467) Casts [#/volume] in Urine by Automated count
1109
8687
1.39
17.55
4.2
3.2
e6/l
0.4
0.4
0.72
907
6530
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
233
1274
1.88
17.52
6.0
4.4
mmol/l
24.8
24.8
0.03
216
1185
(3020630) Protein [Mass/volume] in Serum or Plasma
395
2511
1.64
17.51
2.6
2.7
g/l
67.1
66.3
1.07
350
2300
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
148
687
2.20
17.49
1.5
1.2
u/ml
9.4
6.7
0.14
26
114
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
208
1096
1.95
17.49
2.5
2.2
ug/l
396.8
477.9
0.29
198
1038
(3007461) Platelets [#/volume] in Blood
3697
35317
1.87
17.43
30.5
20.1
e9/l
246.1
246.5
0.14
3631
34425
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
129
567
2.32
17.37
1.3
1.2
titre
150.0
210.0
—
6
16
(3004588) Protein electrophoresis panel - Serum or Plasma
334
2037
1.70
17.36
2.5
2.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
3698
35339
1.87
17.27
30.4
20.0
pg
30.4
30.3
1.65
3656
34842
(3024731) MCV [Entitic volume]
3698
35340
1.87
17.25
30.4
20.0
fl
91.3
90.9
4.87
3656
34846
(3026389) Candida sp identified in Specimen by Organism specific culture
95
363
2.66
17.24
1.4
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
146
678
2.20
17.24
1.5
1.2
u/ml
2.6
2.5
0.07
19
68
(3026361) Erythrocytes [#/volume] in Blood
3698
35344
1.87
17.19
30.5
20.1
e12/l
4.5
4.5
3.43
3620
34367
(3010813) Leukocytes [#/volume] in Blood
3698
35355
1.86
17.01
30.6
20.1
e9/l
6.9
6.7
2.33
3624
34357
(3000963) Hemoglobin [Mass/volume] in Blood
3698
35356
1.86
16.99
30.7
20.2
g/l
135.8
136.7
3.19
3655
34863
(3027273) Bicarbonate [Moles/volume] in Venous blood
259
1482
1.80
16.84
4.1
3.4
mmol/l
25.3
25.2
0.10
252
1433
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
77
267
2.92
16.78
1.3
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
293
1742
1.74
16.70
2.9
3.4
pmol/l
4.4
4.5
1.68
257
1536
(3019060) Gas panel - Arterial blood
339
2098
1.67
16.67
6.3
4.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3198
29622
1.44
16.52
17.1
13.0
ml/min/173m2
81.2
81.6
0.48
2746
24469
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
63
196
3.25
16.52
1.4
1.2
u/ml
1.8
3.5
—
5
12
(3041096) Erythrocytes [Presence] in Urine by Automated
1051
8240
1.38
16.32
4.5
3.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1196
9581
1.36
16.18
4.2
3.3
e6/l
43.1
114.1
2.75
1009
7378
(3011397) Hemoglobin [Presence] in Urine by Test strip
910
6987
1.39
15.99
4.9
3.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
707
5203
1.44
15.78
1.7
1.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1226
9912
1.35
15.46
2.7
2.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
429
2864
1.56
15.43
2.9
2.3
g/l
0.2
0.2
0.65
394
2670
(3009445) Proteinase 3 Ab [Units/volume] in Serum
226
1279
1.81
15.24
2.0
1.6
u/ml
16.3
16.0
0.01
12
39
(3026782) Osmolality of Urine
813
6177
1.40
15.08
3.8
2.8
mosm/kgh2o
555.3
562.0
0.36
701
5268
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
224
1276
1.80
14.79
1.6
1.9
u/l
39.3
38.6
0.21
206
1125
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
132
628
2.14
14.71
1.3
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
54
165
3.30
14.61
2.9
2.6
e9/l
1.1
0.3
0.39
54
159
(40758558) Short blood count panel - Blood
988
7816
1.35
14.14
8.2
6.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
378
2518
1.55
13.68
6.6
3.8
mmol/l
1.2
1.2
0.47
329
2202
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
124
593
2.13
13.66
1.4
1.2
u/ml
267.8
268.3
0.01
79
377
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
117
548
2.17
13.59
2.2
1.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
72
271
2.69
13.54
2.7
2.5
e9/l
1.2
1.1
0.20
46
169
(3023183) Ammonium ion [Moles/volume] in Plasma
136
681
2.03
13.27
3.8
3.1
umol/l
33.6
37.1
0.87
118
581
(3044889) 12 lead EKG panel
2449
22053
1.30
13.17
4.5
3.7
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
364
2430
1.55
13.04
4.2
3.5
kpa
4.7
4.6
0.42
354
2346
(36304419) Bacteria [Presence] in Urine
1050
8470
1.33
12.99
4.1
3.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
285
1799
1.63
12.95
1.6
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
949
7549
1.34
12.91
2.7
2.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
128
634
2.05
12.88
1.6
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
160
857
1.90
12.87
1.4
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
105
484
2.20
12.72
1.6
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
98
439
2.26
12.71
1.8
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
127
634
2.04
12.52
1.6
1.4
u/ml
14.0
16.3
—
5
15
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
286
1823
1.61
12.49
1.4
1.3
au/ml
42.5
52.8
0.22
12
77
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
83
351
2.39
12.30
1.7
1.5
%
61.6
59.0
0.22
57
214
(46235355) HIV 1 and 2 tests - Meaningful Use set
701
5357
1.38
12.29
2.0
1.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
342
2282
1.55
12.27
1.2
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
221
1324
1.71
12.27
1.2
1.1
titre
35.0
145.4
—
6
28
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
127
640
2.02
12.21
1.5
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
144
760
1.93
12.12
2.1
1.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
305
1993
1.58
12.00
9.4
6.6
mmol/l
24.9
24.5
1.06
281
1865
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
691
5289
1.37
11.97
3.4
2.8
e6/l
1.2
1.0
0.69
469
2991
(3018677) aPTT in Platelet poor plasma by Coagulation assay
650
4931
1.38
11.89
2.4
2.1
s
30.0
29.9
0.11
638
4800
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
145
775
1.90
11.77
1.8
2.0
mg/l
9.4
10.8
1.67
136
715
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
700
5386
1.37
11.71
3.0
3.1
mmol/l
2.4
2.4
0.99
610
4715
(3004119) Hemoglobin [Mass/volume] in Venous blood
294
1922
1.57
11.54
3.9
3.4
g/l
128.8
129.9
0.38
283
1870
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
306
2020
1.56
11.51
2.6
2.4
au/ml
34.0
20.0
—
9
98
(21494815) CD4 cells/100 lymphocytes in Specimen
64
247
2.62
11.51
3.0
2.4
%
34.3
43.2
—
9
29
(3030981) Hyaline casts [#/volume] in Urine by Automated count
265
1694
1.61
11.44
3.1
2.9
e6/l
0.3
0.3
0.19
257
1658
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
139
741
1.91
11.38
2.2
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
158
878
1.83
11.37
6.1
4.4
mg/l
1.6
1.5
0.60
146
802
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
31
78
4.00
11.19
1.2
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
104
505
2.09
11.08
6.1
3.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
585
4409
1.38
11.08
1.8
1.6
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
17
25
6.83
11.01
1.1
1.0
u/ml
0.1
0.4
—
8
17
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
158
887
1.81
11.01
2.1
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
56
207
2.73
10.97
2.8
2.5
e6/l
733.9
669.9
0.21
24
78
(3014576) Chloride [Moles/volume] in Serum or Plasma
536
3993
1.40
10.87
7.0
7.0
mmol/l
104.4
104.5
0.29
522
3895
(3016502) Oxygen saturation in Arterial blood
458
3322
1.43
10.82
8.2
7.4
%
95.3
95.6
0.31
434
3196
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
510
3773
1.40
10.77
4.7
4.5
%
31.1
32.1
1.31
371
2580
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
353
2443
1.49
10.65
3.2
2.7
ml/min/173m2
64.7
66.5
0.35
167
950
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2203
19841
1.25
10.57
3.2
2.9
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
37
110
3.39
10.53
2.5
2.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
76
332
2.31
10.52
4.5
3.9
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
161
924
1.77
10.44
2.0
1.7
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
67
278
2.43
10.41
1.6
1.3
%
24.9
30.8
0.66
42
170
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
32
87
3.70
10.40
2.7
2.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
257
1671
1.58
10.34
1.4
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
112
575
1.98
10.27
1.8
1.4
u/ml
118.3
117.6
0.02
25
114
(3000570) Elastase.pancreatic [Mass/mass] in Stool
148
833
1.81
10.25
1.6
1.4
ug/g
261.4
278.6
0.45
95
468
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
109
555
1.99
10.24
1.9
1.5
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
37
115
3.24
9.84
2.5
2.2
%
9.1
9.5
0.05
37
110
(3048929) Epstein Barr virus Ab [Presence] in Serum
162
948
1.74
9.84
1.4
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
80
368
2.20
9.82
1.5
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
81
375
2.18
9.79
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
80
369
2.19
9.76
1.5
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
493
3685
1.39
9.76
7.9
7.1
kpa
5.2
5.1
0.84
458
3519
(3027801) Oxygen [Partial pressure] in Arterial blood
493
3685
1.39
9.76
7.9
7.1
kpa
11.5
12.4
4.52
460
3516
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
29
77
3.79
9.76
1.6
1.5
ug/l
7.9
8.1
0.18
29
77
(3005988) Vibrio sp identified in Specimen by Organism specific culture
80
370
2.19
9.70
1.5
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
756
6039
1.31
9.63
4.5
3.7
ng/l
582.2
631.6
0.05
569
4739
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
55
216
2.57
9.61
2.3
2.3
%
11.6
12.9
0.28
18
102
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
98
492
2.02
9.60
1.8
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
76
347
2.21
9.52
1.1
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
535
4068
1.37
9.52
1.4
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
81
380
2.16
9.49
1.5
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
285
1934
1.51
9.46
1.2
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
126
695
1.84
9.34
1.6
1.6
—
—
—
0
0
(3020891) Body temperature
196
1228
1.63
9.22
6.5
4.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
72
326
2.23
9.21
1.6
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
89
440
2.05
9.11
2.1
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
79
374
2.14
9.06
1.1
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
486
3676
1.37
8.92
8.0
7.1
mmol/l
1.6
1.0
2.09
373
2845
(3007930) Methemoglobin/Hemoglobin.total in Blood
203
1296
1.60
8.86
6.8
4.9
%
0.9
0.9
0.48
186
1215
(3017446) Testosterone [Moles/volume] in Serum or Plasma
399
2925
1.41
8.84
2.4
2.2
nmol/l
12.8
12.9
0.03
349
2582
(3021788) Differential panel - Synovial fluid
100
522
1.94
8.80
1.5
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
361
2605
1.43
8.74
4.0
2.8
ng/l
191.7
201.8
0.13
329
2374
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
51
203
2.53
8.71
2.5
2.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
125
704
1.80
8.69
3.4
3.7
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
76
361
2.13
8.66
2.1
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
156
937
1.69
8.66
3.3
3.6
mg/l
42.5
65.7
0.85
129
766
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
224
1473
1.55
8.61
3.4
2.9
%
1.3
1.2
0.77
224
1464
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
219
1435
1.56
8.55
3.4
2.8
%
0.7
0.6
2.04
214
1379
(1616796) Gas panel - Central venous blood
126
716
1.79
8.51
6.1
3.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
78
377
2.09
8.50
1.5
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
112
616
1.84
8.42
1.6
1.7
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
86
434
2.00
8.35
1.8
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
149
895
1.69
8.28
1.6
1.4
u/l
10.4
8.8
0.71
122
719
(3004809) Band form neutrophils/100 leukocytes in Blood
95
500
1.92
8.19
4.6
3.3
%
1.7
1.6
0.05
73
383
(3034860) Kappa light chains.free [Mass/volume] in Serum
154
937
1.67
8.16
3.3
3.6
mg/l
52.8
60.9
0.39
125
765
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
59
259
2.30
8.16
1.8
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
59
259
2.30
8.16
1.8
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
59
259
2.30
8.16
1.8
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
368
2699
1.40
8.13
8.0
8.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
86
439
1.98
8.10
1.5
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
179
1134
1.61
8.09
4.1
3.3
g/l
0.4
0.3
0.25
93
488
(3021879) Hepatitis B virus core Ab [Presence] in Serum
316
2258
1.43
8.08
1.5
1.4
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
201
1311
1.56
8.03
6.8
4.9
%
1.7
1.7
0.10
183
1225
(40768446) Kidney Pathology biopsy report
36
125
2.90
8.00
2.0
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
388
2880
1.39
7.98
2.3
2.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
509
3942
1.33
7.97
2.1
1.8
%
1.6
1.5
2.25
444
3472
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
455
3472
1.35
7.86
3.6
3.0
umol/l
9.7
8.7
0.24
387
3056
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
149
908
1.67
7.86
3.4
3.6
ratio
1.4
3.0
1.19
11
78
(3034891) Synovial lining cells/100 cells in Synovial fluid
38
138
2.77
7.79
1.6
1.3
%
2.8
3.4
0.11
11
29
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
37
133
2.80
7.73
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1491
13158
1.22
7.72
4.8
5.0
ug/l
2.2
3.5
2.47
1316
11839
(3017732) Neutrophils [#/volume] in Blood
299
2134
1.43
7.70
3.0
2.8
e9/l
3.9
4.1
0.78
212
1676
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
61
280
2.20
7.62
1.4
1.1
u/l
57.8
59.7
0.10
37
189
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
80
408
1.98
7.58
6.7
6.6
mg/l
11.1
11.9
0.81
74
379
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
42
164
2.58
7.50
1.2
1.1
ratio
1.1
1.0
0.24
15
58
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
420
3190
1.35
7.48
2.3
2.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
138
836
1.67
7.47
3.3
3.7
mmol/l
24.3
24.9
0.65
117
719
(3018405) Lactate [Moles/volume] in Arterial blood
174
1117
1.58
7.47
5.3
3.7
mmol/l
1.5
1.4
0.48
169
1099
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
99
545
1.84
7.47
1.4
1.2
u/ml
26.1
44.1
0.58
12
49
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
18
41
4.41
7.42
1.2
2.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
962
8142
1.24
7.41
1.8
1.6
mmol/l
1.5
1.4
1.83
823
6813
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
260
1822
1.46
7.39
1.8
1.6
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
403
3049
1.36
7.36
8.9
7.8
g/l
123.1
122.7
0.15
384
2937
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
212
1429
1.51
7.31
1.6
1.7
g/l
1.6
1.5
0.65
179
1235
(3014111) Lactate [Moles/volume] in Serum or Plasma
375
2809
1.37
7.29
6.3
7.1
mmol/l
1.4
1.4
0.66
356
2691
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
135
820
1.67
7.24
1.5
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
67
326
2.07
7.24
1.5
1.2
u/ml
43.0
43.4
—
6
17
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
49
210
2.35
7.20
1.8
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
268
1900
1.44
7.17
1.2
1.2
iu/ml
111.7
140.0
0.72
93
678
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
20
51
3.94
7.15
4.7
8.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
11
16
6.89
7.15
3.1
3.4
—
—
—
0
0
(3010421) pH of Blood
140
862
1.65
7.13
7.3
4.1
ph
7.4
7.4
1.68
120
719
(44813793)
42
169
2.50
7.07
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
51
225
2.28
7.03
2.5
1.7
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
46
194
2.39
7.01
2.3
2.6
e6/l
753.4
500.7
0.71
40
164
(40761536) Microorganisms panel - Urine sediment
353
2636
1.37
7.00
5.8
3.7
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
123
736
1.69
6.99
7.5
4.4
kpa
8.4
8.5
0.20
123
721
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
19
48
3.97
6.88
2.4
2.3
mg/l
25.7
20.5
—
5
10
(3034274) Bile acid [Moles/volume] in Serum --fasting
60
286
2.12
6.86
1.7
2.6
umol/l
5.0
8.2
0.87
40
199
(3003888) Timothy IgE Ab [Units/volume] in Serum
84
453
1.87
6.79
1.1
1.1
u/ml
4.9
4.6
0.09
42
224
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
125
758
1.67
6.77
1.1
1.1
u/ml
19.4
4.0
0.40
13
94
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
167
1088
1.56
6.75
2.0
1.8
nmol/l
39.7
40.8
0.27
161
1049
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
54
249
2.19
6.71
2.0
1.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
156
1003
1.58
6.68
8.3
5.7
mmol/l
1.4
1.3
0.25
141
882
(44806071)
15
32
4.70
6.68
1.1
1.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
84
456
1.86
6.66
2.3
2.2
titre
26.8
2.9
—
5
12
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
164
1068
1.56
6.65
2.3
2.5
g/l
2.9
3.1
2.29
125
849
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
38
151
2.53
6.59
1.8
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
38
151
2.53
6.59
1.8
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
38
151
2.53
6.59
1.8
1.8
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
23
69
3.35
6.54
2.0
1.6
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
148
947
1.58
6.48
5.5
4.0
mmol/l
3.9
3.9
0.13
140
880
(3012501) Base excess in Blood by calculation
120
732
1.66
6.38
7.5
4.3
mmol/l
2.5
2.5
0.07
85
496
(3042631) Mycobacterium sp identified in Specimen
78
420
1.87
6.36
2.9
2.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
65
329
1.99
6.35
1.8
1.6
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
120
733
1.66
6.35
7.5
4.3
kpa
5.0
5.0
0.19
120
719
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
172
1151
1.52
6.19
2.2
2.4
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
44
193
2.29
6.18
12.9
13.9
nmol/l
778.1
816.5
0.21
39
185
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
61
305
2.02
6.18
1.8
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
31
115
2.71
6.17
1.1
1.1
miu/ml
1790.2
1460.2
0.87
31
115
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
31
115
2.71
6.17
1.9
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
31
115
2.71
6.17
1.9
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
172
1152
1.52
6.16
2.2
2.4
g/l
7.3
7.4
0.20
128
869
(3008898) HLA-B27 [Presence]
154
1008
1.55
6.13
1.1
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
37
151
2.46
6.10
1.9
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
141
907
1.58
6.06
2.6
2.2
u/l
3625.5
5553.6
0.51
48
351
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
223
1579
1.44
6.05
4.6
4.7
mmol/l
23.8
24.1
0.59
196
1436
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
171
1150
1.51
6.02
2.2
2.4
g/l
4.0
3.8
0.80
121
828
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
12
23
5.23
6.00
1.0
1.1
u/ml
0.0
0.1
—
6
15
(3013637) Mi-2 Ab [Presence] in Serum
22
68
3.25
5.99
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
22
68
3.25
5.99
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
22
68
3.25
5.99
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
22
68
3.25
5.99
1.0
1.0
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
21
63
3.35
5.99
1.3
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
71
380
1.88
5.93
1.3
1.6
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
40
172
2.34
5.90
2.0
1.5
u/l
4.7
7.1
0.60
18
81
(3028626) Oxygen [Partial pressure] in Capillary blood
125
788
1.61
5.86
4.4
4.1
kpa
8.8
8.2
2.76
112
726
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
111
680
1.65
5.84
1.6
1.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
11
20
5.51
5.80
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
82
463
1.79
5.78
6.1
5.3
umol/l
375.3
365.5
0.23
71
408
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
41
180
2.29
5.77
1.9
1.6
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
26
91
2.87
5.77
1.3
1.2
g/l
37.6
39.7
0.52
15
50
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
24
81
2.98
5.68
2.9
2.9
—
—
—
0
0
(3039000) Anion gap in Blood
116
726
1.62
5.62
9.4
6.4
mmol/l
11.2
11.3
0.05
101
650
(3018572) Chloride [Moles/volume] in Blood
116
727
1.61
5.59
9.4
6.4
mmol/l
104.9
105.4
0.51
101
651
(3013293) Extractable nuclear Ab [Presence] in Serum
14
33
4.25
5.55
2.1
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
30
116
2.60
5.54
1.9
1.9
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
78
441
1.78
5.49
1.1
1.1
g/l
1.5
1.5
0.57
73
399
(3017354) Segmented neutrophils/100 leukocytes in Blood
59
305
1.95
5.48
3.8
3.1
%
55.2
58.7
0.43
40
191
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
39
173
2.27
5.38
1.4
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
31
124
2.51
5.36
1.2
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
112
704
1.61
5.35
1.7
1.6
e6/l
10938.4
13251.0
0.25
88
519
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
27
102
2.66
5.23
1.5
1.4
pmol/l
12.2
15.6
2.18
22
85
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
38
169
2.26
5.22
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
156
1062
1.49
5.22
1.6
1.7
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
25
91
2.76
5.19
1.6
1.4
nmol/l
95.1
137.0
1.04
19
71
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
94
571
1.66
5.15
1.6
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
28
109
2.58
5.12
2.1
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
332
2581
1.31
5.07
1.8
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
107
675
1.60
5.06
3.4
2.4
%
16.2
16.3
0.09
57
333
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
156
1070
1.48
5.04
2.2
2.5
g/l
10.5
10.1
0.43
129
918
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
85
506
1.69
5.03
1.2
1.1
u/ml
3.7
1.3
0.53
37
187
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
46
225
2.06
5.01
1.0
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
69
388
1.79
4.98
2.1
1.9
titre
4502.9
1212.6
—
7
19
(3028271) Lactate [Moles/volume] in Capillary blood
85
509
1.68
4.93
2.5
1.8
mmol/l
1.8
1.7
0.43
85
499
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
51
262
1.96
4.87
2.0
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
128
851
1.52
4.83
1.3
1.3
titre
66.4
96.3
1.24
11
71
(3008295) Osmolality of Serum or Plasma
57
306
1.88
4.78
1.2
1.4
mosm/kgh2o
281.1
280.7
0.05
46
235
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
48
243
1.99
4.78
1.3
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
23
84
2.75
4.77
1.7
1.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
33
144
2.30
4.77
3.2
2.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
215
2881
0.73
4.73
1.9
1.7
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
122
807
1.53
4.72
1.8
1.4
iu/ml
44.5
9.6
—
6
19
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
122
807
1.53
4.72
2.8
2.4
ug/min
194.6
112.6
0.90
81
507
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
38
177
2.16
4.71
1.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
57
308
1.86
4.70
1.3
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
34
152
2.25
4.65
1.2
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
55
295
1.88
4.64
1.2
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
128
859
1.51
4.63
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
127
853
1.51
4.58
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
126
846
1.51
4.56
1.3
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
593
5004
1.22
4.52
3.7
3.0
e6/l
2.7
1.8
1.28
379
2725
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
38
181
2.11
4.47
2.0
1.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
30
130
2.32
4.42
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
30
130
2.32
4.42
1.3
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
402
3263
1.26
4.39
4.5
3.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
904
7949
1.18
4.37
4.9
4.1
%
89.1
88.6
0.24
884
7750
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
35
163
2.16
4.36
1.5
1.1
u/l
74.0
85.7
0.60
27
140
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
201
1485
1.37
4.35
1.1
1.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
52
281
1.86
4.31
1.3
1.3
e6/l
207709.1
112526.4
0.28
38
202
(3003181) Sodium [Moles/volume] in Urine
80
491
1.64
4.28
1.3
1.4
mmol/l
61.5
64.7
0.32
61
404
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
129
884
1.47
4.25
2.0
2.4
g/l
38.6
37.6
1.06
104
771
(40761539) Cells [Type] in Urine sediment by Light microscopy
22
84
2.63
4.22
1.4
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
36
172
2.10
4.22
1.4
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
32
146
2.20
4.20
6.3
3.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
140
978
1.45
4.18
2.4
2.5
g/l
0.9
1.1
0.16
114
847
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
31
140
2.22
4.17
1.3
1.1
u/l
45.0
33.3
0.17
24
100
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
45
235
1.93
4.15
1.8
1.3
mmol/l
2.1
2.0
0.10
39
221
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
52
285
1.84
4.14
1.4
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
65
381
1.72
4.14
2.1
2.1
mg/l
28.7
20.5
0.82
17
94
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
17
57
2.99
4.12
1.0
1.8
ug/l
1.7
1.6
—
6
31
(3028679) Herpes simplex virus Ab [Presence] in Serum
31
141
2.21
4.11
1.2
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
51
279
1.84
4.09
2.0
1.4
promille
1.2
1.3
0.34
46
219
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
30
135
2.23
4.08
1.8
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
43
223
1.94
4.05
1.2
1.1
—
27.2
—
0
5
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
171
1246
1.39
4.05
2.2
3.2
u/ml
30.3
55.6
2.40
163
1206
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
36
176
2.06
3.99
1.4
1.5
u/l
4.9
7.7
1.76
31
151
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
124
856
1.46
3.96
1.3
1.3
miu/ml
164.9
209.8
0.77
50
392
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
28
124
2.27
3.96
2.8
1.7
umol/l
67.6
151.9
1.19
12
72
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
18
64
2.82
3.95
1.1
1.1
—
—
—
0
0
(4035726)
331
2664
1.26
3.90
1.5
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
91
591
1.55
3.89
3.4
3.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
10
24
4.17
3.88
1.5
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
81
512
1.59
3.88
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
71
435
1.64
3.86
1.1
1.1
u/ml
0.9
0.8
0.10
30
170
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
30
139
2.17
3.82
1.3
1.1
u/l
110.6
95.7
0.24
25
103
(3023419) Bacteria identified in Sputum by Culture
64
383
1.68
3.81
3.0
2.6
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
15
49
3.07
3.80
1.7
2.0
ng/l
97.8
179.3
1.59
15
49
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
381
3128
1.24
3.78
3.5
4.2
ug/l
7.6
26.2
2.67
306
2560
(3044290) Cell count panel - Cerebral spinal fluid
93
611
1.53
3.78
1.6
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
37
187
1.99
3.77
3.4
2.6
%
34.2
39.2
0.50
14
71
(3000012) Reticulocyte production index
33
160
2.07
3.76
1.4
1.5
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
13
39
3.34
3.76
1.2
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
67
408
1.65
3.74
1.1
1.1
u/ml
0.6
1.3
0.92
16
88
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
38
195
1.96
3.72
1.4
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
55
319
1.73
3.67
1.2
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1165
10574
1.14
3.61
4.4
4.2
%
22.5
21.9
0.56
554
5133
(3014133) Dog dander IgE Ab [Units/volume] in Serum
58
344
1.70
3.59
1.1
1.0
u/ml
2.3
1.8
0.26
24
116
(3020123) Porphyrins [Interpretation] in Serum or Plasma
7
9
7.79
3.55
1.1
1.1
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
32
157
2.05
3.55
1.6
1.1
u/l
18.0
17.3
0.03
25
131
(3006184) Hemoglobin [Mass/volume] in Capillary blood
103
702
1.48
3.55
2.7
2.2
g/l
127.7
130.2
0.44
70
502
(3006442) Creatine [Moles/volume] in Serum or Plasma
40
213
1.89
3.53
1.3
1.5
umol/l
70.1
74.0
—
7
15
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
151
1105
1.38
3.53
2.6
3.0
u/ml
0.3
0.3
0.93
86
615
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
37
192
1.94
3.52
1.4
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
9
17
5.30
3.51
1.1
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
111
770
1.45
3.50
1.4
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
25
112
2.24
3.47
5.5
4.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
93
624
1.50
3.46
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
93
624
1.50
3.46
1.3
1.3
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
28
132
2.13
3.45
1.8
1.6
iu/ml
—
1690955.0
—
0
10
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
80
520
1.55
3.45
1.1
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
109
762
1.44
3.32
1.6
1.4
mg/l
561.1
526.9
0.32
101
720
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
112
787
1.44
3.32
1.2
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
96
656
1.48
3.29
3.4
3.6
u/ml
640.9
774.0
0.09
88
606
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
49
285
1.73
3.28
1.2
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2731
26241
1.14
3.27
23.4
16.8
%
13.7
13.7
1.31
2675
25645
(44790049)
60
369
1.64
3.27
2.1
1.5
—
—
—
0
0
(44790047)
60
369
1.64
3.27
2.1
1.5
—
—
—
0
0
(44806118)
60
369
1.64
3.27
2.1
1.5
—
—
—
0
0
(44790048)
60
369
1.64
3.27
2.1
1.5
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
31
156
2.00
3.24
2.0
1.5
u/field
1.8
2.4
0.34
24
116
(44816559) Phosphatidylethanol [Mass/volume] in Blood
91
618
1.48
3.22
1.6
1.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
51
302
1.70
3.21
1.4
1.3
g/l
3.0
3.1
0.10
33
223
(3021387) Prolactin [Units/volume] in Serum or Plasma
137
1004
1.38
3.20
1.8
1.6
mu/l
300.5
291.1
0.17
123
914
(3004451) EKG impression Narrative
29
143
2.04
3.20
1.2
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
54
325
1.67
3.20
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
41
228
1.81
3.19
1.1
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
8
15
5.34
3.19
2.8
4.9
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
31
157
1.98
3.19
2.5
2.1
—
31.9
—
0
16
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
56
341
1.65
3.18
2.4
2.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
21
91
2.31
3.16
1.5
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
252
2017
1.27
3.16
7.7
7.5
mmol/l
24.5
24.8
0.73
252
2003
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
50
296
1.70
3.15
1.1
1.0
u/ml
0.0
0.1
0.35
12
51
(43055514) Macroprolactin [Presence] in Serum or Plasma
16
61
2.63
3.13
1.3
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
445
3789
1.20
3.10
1.5
1.4
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
63
398
1.59
3.10
3.2
2.3
mmol/l
4.1
4.1
0.07
63
391
(3035285) Chloride [Moles/volume] in Venous blood
63
398
1.59
3.10
3.2
2.3
mmol/l
105.6
105.5
0.08
63
391
(3000492) Spirometry study
354
2949
1.22
3.10
1.6
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
12
39
3.08
3.08
1.1
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
26
125
2.09
3.07
3.8
2.9
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
21
93
2.26
3.03
1.5
2.2
e6/l
14787.6
3321.1
—
10
55
(21494755) Public health laboratory ask at order entry panel
247
3050
0.80
3.00
1.3
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
20
87
2.31
3.00
2.1
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
114
821
1.40
2.98
1.4
1.3
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
50
302
1.66
2.95
1.4
1.3
g/l
6.7
6.9
0.14
33
221
(3024139) IgG subclass 3 [Mass/volume] in Serum
50
302
1.66
2.95
1.4
1.3
g/l
0.5
0.4
0.28
34
223
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
10
30
3.34
2.90
1.2
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
18
76
2.37
2.89
1.4
2.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
68
446
1.53
2.87
1.2
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
6
9
6.67
2.86
1.0
1.0
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
57
359
1.60
2.86
3.1
24.5
mmol/l
7.0
7.4
0.38
43
299
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
49
297
1.66
2.86
3.1
2.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
20
89
2.25
2.86
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
51
314
1.63
2.81
2.4
2.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
13
47
2.77
2.81
1.5
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
59
377
1.57
2.80
1.6
1.4
pmol/l
351.6
317.6
0.19
44
301
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
90
2.23
2.79
1.4
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
35
194
1.81
2.79
2.4
2.1
min
515.3
490.7
0.80
24
140
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
151
1.93
2.79
1.1
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
60
388
1.55
2.72
3.3
2.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
123
913
1.36
2.71
3.4
3.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
31
167
1.86
2.71
1.1
1.1
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
27
139
1.95
2.69
1.6
1.8
—
8.2
—
0
14
(3051651) Icteric interference index of Serum or Plasma
32
175
1.84
2.67
4.1
3.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
54
342
1.59
2.67
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
169
1317
1.30
2.67
2.4
2.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
59
382
1.55
2.66
1.4
1.3
nmol/l
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
116
856
1.37
2.66
2.1
2.4
g/l
0.0
0.0
0.25
106
790
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
12
43
2.80
2.64
2.9
2.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
341
2880
1.20
2.62
2.6
2.4
u/l
40.1
55.0
0.37
290
2481
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
96
688
1.41
2.62
1.5
1.8
iu/l
3.7
4.5
0.44
35
239
(3023487) Leukocytes [#/volume] in Peritoneal fluid
22
106
2.08
2.62
1.6
2.4
e6/l
1070.3
7350.7
0.46
17
81
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
22
106
2.08
2.62
1.1
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
15
61
2.46
2.61
1.1
2.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
14
55
2.55
2.61
1.0
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
14
55
2.55
2.61
1.2
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
37
215
1.73
2.55
2.0
1.5
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
14
56
2.51
2.53
1.0
1.1
u/ml
2.5
0.5
—
9
30
(3023430) Cat dander IgE Ab [Units/volume] in Serum
50
318
1.58
2.46
1.1
1.0
u/ml
2.8
3.1
0.09
22
113
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
15
63
2.39
2.46
3.6
2.1
umol/l
22.0
17.3
0.55
15
63
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
46
287
1.61
2.45
1.1
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
218
1773
1.24
2.45
11.3
9.5
—
—
—
0
0
(4062490)
48
303
1.59
2.44
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
189
1513
1.26
2.44
1.3
1.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
10
34
2.95
2.41
1.3
1.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
10
34
2.95
2.41
1.0
1.4
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
5
8
6.26
2.37
1.0
1.1
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
107
796
1.35
2.37
2.2
2.5
g/l
0.0
0.0
0.00
97
734
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
30
168
1.79
2.36
8.7
6.8
u/ml
118.8
13259.4
—
9
48
(4198724)
24
125
1.93
2.35
2.1
3.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
29
161
1.81
2.35
1.0
1.0
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
18
84
2.15
2.34
1.2
1.5
g/l
10.2
13.0
—
10
62
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
66
452
1.47
2.33
1.4
1.2
u/ml
2.9
5.2
1.62
28
195
(4024509)
43
268
1.61
2.31
1.4
1.6
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
14
59
2.38
2.29
1.9
1.9
—
—
—
0
0
(4015189)
18
85
2.12
2.28
4.6
2.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
8
23
3.48
2.27
5.0
2.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
93
682
1.37
2.26
1.5
1.3
mmol/l
3.8
3.8
0.25
84
636
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
205
1673
1.24
2.25
2.1
2.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
63
432
1.47
2.23
1.2
1.1
%
115.6
114.3
0.11
57
394
(3044007) Cell count panel - Peritoneal fluid
18
86
2.10
2.22
2.6
2.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
25
135
1.86
2.22
1.7
2.1
umol/l
30.3
28.5
0.47
25
128
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
5
9
5.56
2.21
1.2
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
24
128
1.88
2.21
3.2
2.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
105
789
1.34
2.20
2.2
2.5
g/l
0.0
0.0
0.00
96
734
(3009542) Hematocrit [Volume Fraction] of Blood
2983
29046
1.11
2.19
19.8
14.8
%
39.9
40.1
0.44
1906
21087
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
58
393
1.48
2.18
1.3
1.5
nmol/l
0.3
0.4
0.50
44
307
(3033799) Differential panel - Peritoneal fluid
19
94
2.03
2.15
2.2
2.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
59
403
1.47
2.14
1.6
1.5
mu/l
85.7
83.4
0.02
50
362
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
62
430
1.45
2.09
1.3
1.3
nmol/l
0.7
0.6
0.43
57
414
(3000060) B lymphocytes [#/volume] in Blood
16
75
2.14
2.08
1.9
2.4
e6/l
184.5
228.2
0.23
11
39
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
384
3350
1.16
2.06
1.6
1.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
51
341
1.50
2.06
1.5
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
30
176
1.71
2.05
2.1
1.7
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
7
20
3.50
2.05
3.3
3.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
21
110
1.91
2.05
1.3
1.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
33
199
1.66
2.05
1.1
1.3
mmol/l
28.0
37.1
1.24
26
177
(40758292) HTLV I+II Ab panel - Serum
11
44
2.50
2.01
1.1
1.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
18
90
2.00
2.00
1.0
1.2
%
70.1
87.4
—
7
45
(3004775) Volume in Urine collected for unspecified duration
42
271
1.56
2.00
2.6
2.2
ml
751.7
625.5
0.85
29
174
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
32
193
1.66
1.99
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
32
193
1.66
1.99
1.1
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
153
1891
0.80
1.97
1.6
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
70
503
1.40
1.96
2.7
3.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
18
91
1.98
1.95
1.0
1.1
%
69.0
89.3
—
7
44
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
11
4.55
1.94
5.0
5.2
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
5
11
4.55
1.94
5.0
4.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
14
64
2.19
1.94
1.0
1.4
—
—
—
0
0
(4306422)
62
438
1.42
1.92
1.2
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
30
484
0.62
1.91
1.5
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
42
629
0.66
1.91
1.5
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
26
150
1.74
1.90
3.8
4.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
19
99
1.92
1.90
1.1
1.2
—
0.1
—
0
6
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
7
22
3.19
1.88
1.0
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
74
542
1.37
1.87
1.5
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
21
114
1.85
1.87
1.1
2.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
40
260
1.54
1.86
1.2
1.2
nmol/l
389.7
375.8
0.15
27
226
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
161
1311
1.24
1.86
2.0
1.9
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
55
384
1.44
1.83
1.2
1.1
u/ml
0.8
2.8
4.05
16
180
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
19
101
1.89
1.80
1.3
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
7
23
3.05
1.80
1.3
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
17
87
1.96
1.79
1.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
30
475
0.63
1.78
1.5
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
101
782
1.30
1.78
5.6
4.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
84
634
1.33
1.77
1.8
1.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
30
473
0.63
1.76
1.5
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
14
67
2.09
1.75
2.1
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
14
272
0.51
1.75
1.1
1.2
—
—
—
0
0
(4146454)
49
338
1.46
1.74
2.2
2.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
100
776
1.30
1.74
1.2
1.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
9
36
2.50
1.74
1.7
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
67
490
1.37
1.73
1.4
1.7
g/l
0.7
0.8
0.69
47
385
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
11
48
2.30
1.70
1.1
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
11
48
2.30
1.70
1.1
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
11
48
2.30
1.70
1.1
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
37
242
1.53
1.70
2.2
1.6
g/l
0.9
1.0
1.28
37
242
(3012441) Differential panel - Pleural fluid
48
332
1.45
1.69
1.3
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
123
986
1.26
1.66
2.5
2.5
%
89.4
90.4
0.19
114
926
(3030313) Adrenal Ab [Titer] in Serum
6
19
3.16
1.66
1.3
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
8
31
2.58
1.66
3.3
2.4
u/field
1.1
0.5
—
8
31
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
25
2.80
1.65
1.0
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
7
25
2.80
1.65
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
17
90
1.89
1.65
1.4
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
33
212
1.56
1.65
1.3
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
74
556
1.34
1.63
1.3
1.3
u/l
37.1
34.8
0.07
69
480
(3006922) Hepatitis E virus Ab [Presence] in Serum
32
205
1.57
1.62
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
63
463
1.37
1.60
1.5
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
55
395
1.40
1.60
1.1
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
8
32
2.50
1.59
1.0
1.2
umol/24h
1.9
1.8
—
8
32
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
15
77
1.95
1.59
2.0
1.7
—
—
—
0
0
(3036489) Thrombin time
145
1192
1.22
1.58
2.4
2.2
s
21.2
21.5
0.26
116
1052
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
63
466
1.36
1.55
1.3
1.2
u/ml
1.9
4.0
1.37
23
155
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
54
390
1.39
1.53
1.4
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
21
2.86
1.50
1.0
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
31
202
1.54
1.48
1.1
1.3
u/ml
0.3
0.5
0.40
12
92
(3051611) Lipemic interference index of Serum or Plasma
42
292
1.44
1.48
3.8
3.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
52
709
0.73
1.47
1.4
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
45
2.23
1.46
1.0
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
41
579
0.71
1.44
1.4
1.4
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
16
3.13
1.44
9.2
5.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
57
421
1.36
1.43
1.2
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
12
59
2.04
1.43
2.3
2.3
ug/l
3.3
3.9
—
7
24
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
41
578
0.71
1.43
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
41
578
0.71
1.43
1.4
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
59
439
1.35
1.42
1.2
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
22
133
1.66
1.42
1.1
1.1
iu/ml
269.3
205.1
0.30
22
133
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
41
577
0.71
1.41
1.4
1.4
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
25
157
1.60
1.40
2.2
2.7
mmol/l
9.9
9.4
0.21
17
126
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
33
222
1.49
1.38
1.2
1.1
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
13
67
1.94
1.38
1.5
1.4
g/l
31.5
25.2
—
7
48
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
89
1115
0.79
1.37
1.5
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
85
670
1.27
1.37
2.6
2.0
nmol/l
0.9
0.9
0.37
67
565
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
41
2.20
1.37
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
91
724
1.26
1.36
1.3
1.2
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
5
17
2.94
1.36
1.0
1.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
63
478
1.32
1.35
1.3
1.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
14
75
1.87
1.34
1.3
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
13
68
1.91
1.33
1.2
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
18
105
1.72
1.33
1.1
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
98
792
1.24
1.30
2.5
3.3
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
18
2.78
1.28
1.0
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
58
439
1.33
1.27
1.0
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
48
2.09
1.27
1.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
28
186
1.51
1.26
1.4
1.5
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
19
115
1.66
1.24
1.8
2.6
ug/l
2.0
1.2
0.44
19
106
(3019174) dRVVT (LA screen)
6
25
2.40
1.24
1.2
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
74
582
1.28
1.24
3.1
3.1
nmol/l
0.8
0.8
0.04
55
447
(3039443) Prostate specific Ag panel - Serum or Plasma
59
766
0.77
1.24
1.5
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
324
2907
1.12
1.24
1.4
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
25
163
1.54
1.22
1.5
1.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
31
212
1.47
1.22
1.2
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
43
313
1.38
1.22
3.1
3.1
mg/l
42.4
58.6
0.23
36
239
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
5
19
2.63
1.21
2.0
2.0
mg/l
2.6
3.2
—
5
19
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
40
288
1.39
1.21
4.1
5.0
u/ml
16.4
73.4
—
10
80
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
113
937
1.21
1.19
1.4
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
13
71
1.83
1.19
2.3
2.3
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
8
38
2.11
1.18
1.3
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
35
486
0.72
1.16
1.9
1.7
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
39
2.05
1.15
1.3
1.2
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
39
2.05
1.15
2.0
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
68
537
1.27
1.12
1.6
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
18
111
1.62
1.12
1.0
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
140
1195
1.18
1.10
1.5
1.4
iu/l
25.3
26.9
0.21
127
1000
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
112
938
1.20
1.09
3.1
2.7
g/l
3.6
3.6
0.03
107
891
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
30
210
1.43
1.08
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
30
210
1.43
1.08
1.3
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
33
2.12
1.05
1.4
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
18
113
1.60
1.05
1.1
1.1
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
82
669
1.23
1.04
1.6
1.5
e6/l
381.7
1079.7
1.25
66
549
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
26
179
1.46
1.02
17.0
12.3
mmol/l
0.6
0.6
0.39
26
163
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
17
106
1.61
1.02
1.1
1.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
51
394
1.30
1.02
1.4
1.4
e6/l
2855.6
2367.1
0.12
38
282
(3006653) Thiamine [Moles/volume] in Blood
25
171
1.46
1.02
1.4
1.2
nmol/l
150.3
136.0
0.47
25
171
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
9
48
1.88
1.00
1.1
1.1
%
99.6
88.9
—
9
48
(1761868) Lipid panel - Serum or Plasma
1092
11413
0.94
0.99
3.3
2.8
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
13
76
1.71
0.98
1.2
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
23
2.18
0.98
1.4
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
14
84
1.67
0.97
5.8
8.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
9
50
1.80
0.96
2.8
2.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
18
116
1.55
0.96
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
29
207
1.40
0.96
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
29
207
1.40
0.96
1.3
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
81
669
1.22
0.94
1.5
1.4
e6/l
9.6
24.4
0.87
66
521
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
37
1.89
0.94
2.4
2.1
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
6
28
2.14
0.91
11.0
8.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
6
28
2.14
0.91
1.5
1.8
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
16
102
1.57
0.90
1.0
1.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
29
210
1.38
0.90
1.3
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
21
143
1.47
0.89
5.0
13.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
26
185
1.41
0.89
1.5
1.8
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
66
540
1.23
0.86
1.1
1.1
iu/ml
19.9
1040.8
0.55
20
131
(3000764) Benzodiazepines [Presence] in Urine
135
1178
1.15
0.85
2.0
2.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
45
352
1.28
0.85
1.4
1.4
e6/l
121435.2
86719.8
0.18
24
205
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
36
273
1.32
0.85
1.1
1.1
u/ml
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
15
96
1.56
0.84
1.9
1.7
—
—
—
0
0
(3014891) Appearance of Pleural fluid
8
45
1.78
0.84
1.5
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
107
921
1.17
0.82
2.2
2.4
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
32
1.88
0.81
1.5
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
16
105
1.53
0.81
1.3
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
15
97
1.55
0.81
5.5
7.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
14
89
1.58
0.81
1.2
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
24
172
1.40
0.80
2.1
2.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
58
473
1.23
0.79
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
28
207
1.36
0.79
1.3
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
33
1.82
0.79
1.3
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
25
0.00
0.79
0.0
5.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
191
1717
1.12
0.78
8.8
9.4
mmol/l
24.3
24.2
0.14
172
1616
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
150
0.60
0.78
1.4
3.4
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
82
1.59
0.78
1.2
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
82
1.59
0.78
1.2
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
23
165
1.40
0.77
2.1
2.4
—
—
—
0
0
(3003577) Lead [Moles/volume] in Blood
0
27
0.00
0.77
0.0
1.2
—
0.1
—
0
6
(3002523) Influenza virus A Ag [Presence] in Specimen
58
475
1.22
0.77
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
82
695
1.18
0.77
3.4
3.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
64
530
1.21
0.76
1.2
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
16
107
1.50
0.76
4.1
2.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
96
826
1.17
0.75
1.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
221
2012
1.10
0.73
2.7
2.8
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
25
2.00
0.72
3.8
3.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
134
1187
1.13
0.72
2.0
2.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
16
109
1.47
0.70
1.1
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
26
1.92
0.70
1.0
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
35
274
1.28
0.69
1.1
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
39
310
1.26
0.69
1.4
1.4
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
27
1.85
0.68
1.6
2.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
131
1164
1.13
0.68
2.0
2.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
134
1193
1.13
0.67
2.0
2.3
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
30
231
1.30
0.67
1.3
1.1
mg/l
337.5
283.9
0.40
24
196
(3045414) Leukocytes [Presence] in Urine
154
1384
1.12
0.66
1.7
1.8
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
24
179
1.34
0.66
1.1
1.1
u/l
1.1
1.1
0.31
11
85
(3003338) MCHC [Mass/volume]
2739
27013
1.05
0.66
25.8
17.5
g/l
332.8
333.0
0.48
2720
26799
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
71
605
1.18
0.65
1.2
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
78
1.54
0.65
1.2
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
44
1.59
0.65
17.3
9.9
mmol/l
5.1
6.3
—
7
44
(3023383) Lactate [Moles/volume] in Pleural fluid
14
95
1.48
0.64
1.4
1.4
mmol/l
3.7
3.5
0.07
14
86
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
5
29
1.73
0.64
1.4
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
37
296
1.25
0.63
1.3
1.6
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
30
234
1.28
0.62
1.9
2.2
u/field
2.9
1.9
0.41
19
93
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
12
79
1.52
0.62
1.1
1.2
pmol/l
217.3
294.6
—
7
56
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
79
1.52
0.62
1.2
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
13
88
1.48
0.60
1.5
1.4
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
13
88
1.48
0.60
1.4
1.3
ug/l
1753.9
165.2
—
8
41
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
8
51
1.57
0.60
1.1
1.1
—
7.9
—
0
9
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
15
105
1.43
0.60
1.1
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
31
245
1.27
0.59
1.3
1.3
titre
125.0
197.6
—
10
51
(3026470) Cobalt [Mass/volume] in Blood
27
210
1.29
0.58
2.1
2.1
ug/l
5.0
3.1
0.31
22
185
(3014599) Egg white IgE Ab [Units/volume] in Serum
19
140
1.36
0.58
1.1
1.0
u/ml
3.0
0.6
—
7
28
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
31
247
1.26
0.56
1.4
1.4
mmol/l
12.2
12.5
0.04
12
67
(3023511) Choriogonadotropin [Units/volume] in Urine
53
449
1.18
0.55
1.6
1.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
30
240
1.25
0.53
1.3
1.2
mg/l
40.1
44.0
0.20
24
195
(3025018) Bordetella pertussis Ab [Titer] in Serum
23
178
1.29
0.53
1.2
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
10
66
1.52
0.52
5.0
7.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
20
152
1.32
0.52
1.4
1.8
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
18
135
1.33
0.51
1.1
1.0
u/ml
4.2
1.1
—
8
35
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
17
127
1.34
0.49
1.1
1.2
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
44
519
0.85
0.49
1.5
1.6
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
26
208
1.25
0.47
2.2
2.1
ug/l
3.1
2.0
0.35
18
178
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
10
68
1.47
0.47
1.2
1.2
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
49
1.43
0.46
1.0
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
15
112
1.34
0.44
1.1
1.1
ng/l
1212.5
282.3
—
6
27
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
34
405
0.84
0.44
1.5
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
166
1540
1.08
0.43
5.0
3.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
13
174
0.75
0.43
6.3
2.7
u/l
227.7
204.4
0.31
13
174
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
31
1.61
0.43
1.2
3.0
—
—
—
0
0
(1002224) Polysomnography panel
139
1281
1.09
0.42
1.1
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
56
1.43
0.42
1.3
1.5
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
6
92
0.65
0.42
4.0
6.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
6
92
0.65
0.42
2.0
3.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
32
1.56
0.42
1.4
2.7
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
24
194
1.24
0.42
1.1
1.1
iu/ml
7.1
10.5
—
5
52
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
33
1.52
0.41
1.0
1.0
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
15
0.00
0.41
0.0
1.1
—
8.2
—
0
15
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
17
0.00
0.40
0.0
1.0
—
77.7
—
0
9
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
34
1.47
0.40
3.8
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
8
60
1.33
0.40
1.4
1.9
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
13
171
0.76
0.39
1.4
1.6
mmol/l
7.6
8.0
—
7
111
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
1.0
1.5
umol/l
43.6
46.5
—
5
35
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
35
1.43
0.39
1.0
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
35
1.43
0.39
3.0
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
119
1095
1.09
0.39
2.2
2.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
47
538
0.87
0.39
1.2
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
9
66
1.36
0.38
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
38
327
1.16
0.37
3.0
3.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
39
337
1.16
0.36
1.1
1.1
—
—
—
0
0
(44806420)
13
99
1.31
0.35
2.4
2.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
102
1105
0.92
0.33
1.8
1.7
mg/l
3.4
3.4
0.00
84
770
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
33
284
1.16
0.33
1.4
1.4
pmol/l
42.5
163.9
—
10
93
(40768795) Lymph node Pathology biopsy report
32
276
1.16
0.31
1.3
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
102
1.28
0.30
2.2
2.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
102
1.28
0.30
2.2
2.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
27
314
0.86
0.29
1.7
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
76
827
0.92
0.29
1.1
1.2
—
—
—
0
0
(4268621)
36
316
1.14
0.29
2.5
2.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
64
1.25
0.27
1.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
20
168
1.19
0.27
1.2
1.2
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
5
71
0.70
0.26
1.0
1.2
mg/l
0.4
165.0
—
5
50
(4094501)
92
858
1.07
0.25
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
106
1129
0.94
0.25
1.7
1.8
—
—
—
0
0
(3011648) Oxygen content in Venous blood
23
266
0.86
0.24
3.0
3.6
%
12.4
11.1
0.86
23
266
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
779
7637
1.03
0.24
2.9
3.0
ug/l
0.8
0.8
0.14
524
5055
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
78
1.28
0.24
1.1
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
78
1.28
0.24
1.0
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
36
322
1.12
0.23
1.3
1.4
mmol/l
6.0
6.4
0.80
36
299
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
15
125
1.20
0.22
1.6
1.5
—
—
—
0
0
(37019676) Renin [Units/volume] in Plasma --supine
0
11
0.00
0.21
0.0
1.1
—
9.2
—
0
6
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
10
0.00
0.21
0.0
4.5
—
110.2
—
0
10
(1617658) Protocol used for examination of sentinel lymph nodes
23
201
1.15
0.21
1.1
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
65
698
0.93
0.21
1.7
2.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
11
89
1.24
0.21
1.1
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
22
192
1.15
0.20
6.4
6.7
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
6
49
1.22
0.20
1.3
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
18
155
1.16
0.19
2.4
2.5
umol/l
60.5
52.7
0.58
18
134
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
36
396
0.91
0.19
1.2
1.3
mmol/l
7.5
7.3
0.09
21
304
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
11
133
0.83
0.19
1.0
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
11
90
1.22
0.19
1.0
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
116
1105
1.05
0.19
2.7
3.6
u/ml
201.2
3663.0
0.82
102
952
(3035880) pH of Pleural fluid
21
184
1.14
0.19
1.2
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
22
249
0.88
0.19
1.4
1.7
mmol/l
6.8
6.7
0.03
16
169
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
59
550
1.07
0.18
1.4
1.6
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
14
119
1.18
0.17
1.7
2.0
ug/l
25.8
216.7
0.48
14
108
(4281824)
30
272
1.10
0.17
1.2
1.2
—
—
—
0
0
(4027681)
21
186
1.13
0.17
1.6
1.3
—
—
—
0
0
(4211845)
13
151
0.86
0.15
2.8
3.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
12
139
0.86
0.14
2.9
3.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
18
160
1.13
0.14
1.1
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
34
315
1.08
0.13
1.6
1.4
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
17
151
1.13
0.13
2.0
1.3
%
69.4
63.0
—
5
20
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
23
209
1.10
0.13
1.0
1.1
—
—
—
0
0
(4133840)
10
86
1.16
0.11
1.0
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
67
698
0.96
0.10
3.4
3.4
mg/l
21.3
27.8
0.99
37
445
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
14
156
0.90
0.10
1.3
1.8
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
55
1.09
0.08
1.2
1.0
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
10
113
0.88
0.08
1.6
1.3
nmol/l
20.4
32.1
—
10
94
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
65
1.08
0.08
1.3
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
127
1.10
0.07
1.1
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
148
1510
0.98
0.07
1.8
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
12
108
1.11
0.07
1.2
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
20
214
0.93
0.07
1.7
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
10
89
1.12
0.06
1.6
1.7
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
29
305
0.95
0.06
1.2
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
14
152
0.92
0.06
1.3
1.4
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
35
335
1.05
0.06
1.5
1.9
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
10
90
1.11
0.05
1.4
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
151
0.93
0.05
1.2
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
151
0.93
0.05
1.2
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
21
222
0.95
0.05
2.8
2.3
—
—
—
0
0
(4034850)
97
989
0.98
0.05
9.9
9.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
882
8855
0.99
0.04
1.4
1.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
15
143
1.05
0.01
1.1
1.1
—
—
—
0
0
(3019977) pH of Arterial blood
19
191
0.99
0.00
2.0
2.6
ph
7.4
7.4
—
5
63
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
5
50
1.00
0.00
1.4
1.7
nmol/l
0.5
0.2
—
5
32
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
72
0.97
0.00
1.3
1.2
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
6
59
1.02
0.00
1.5
3.0
—
—
—
0
0
(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
5
51
0.98
0.00
1.8
7.8
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
9
94
0.96
0.00
3.0
1.8
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
7
0.00
0.00
0.0
1.0
—
301.7
—
0
7
(3002619) Bacteria identified in Specimen by Culture
5
54
0.93
0.00
1.4
1.1
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1692.0
—
0
5
(3002079) Sodium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
118.1
—
0
7
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
65
0.92
0.00
1.2
1.3
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
31.2
—
0
5
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
8.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_SEBORRHOEIC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_SEBORRHOEIC | 1.348 [1.2, 1.51] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.629 |
During the follow-up period (1.1.1998 — 31.12.2019), 994 out of 7697 females with L12_SEBORRHOEIC died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_SEBORRHOEIC | 1.588 [1.43, 1.76] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.012 |
During the follow-up period (1.1.1998 — 31.12.2019), 2798 out of 12088 males with L12_SEBORRHOEIC died.
Mortality risk
Mortality risk for people of age
years, who have L12_SEBORRHOEIC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.166% | 0.342% |
| 5 | 0.864% | 1.963% |
| 10 | 2.087% | 4.8% |
| 15 | 4.28% | 8.967% |
| 20 | 7.508% | 15.394% |
Relationships between endpoints
↥Index endpoint: L12_SEBORRHOEIC – Seborrhoeic dermatitis
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data